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Abstract
This study addressed the factors that predict employee response to large-scale change in
the United States pharmaceutical industry. When poorly executed, major organizational
changes such as mergers and acquisitions are often disruptive and costly to organizations
and demoralizing to employees. Although employee responses to change have been
studied in several industries, employee responses during change execution in the
pharmaceutical industry have not been subject to study. The purpose of this correlational
study was to reduce the knowledge gap related to organizational change in the
pharmaceutical industry by evaluating key predictors of employee response to large-scale
change. The theoretical framework consisted of transformational leadership, stakeholder,
and change management theories. The research questions focused on 4 key predictors
(initial change reaction, change communication, involvement in change development, and
perceived change success) and their effect on 2 primary dependent variables: reaction to
change (RC) and support of change (SC). Ninety-eight participants completed the survey
and multiple regression was used to measure associations between predictor variables and
dependent variables. The 4 independent variables in the aggregate predicted RC and the
championing subscale of SC. Individually, none of the independent variables predicted
RC, SC, or any of the SC subscales. The study contributes to positive social change by
providing leadership with information in guiding creation of a supportive work
environment during organizational change and to inspire employees developing medical
innovations to fulfill global health needs, while creating skilled jobs and generating
profit.
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Chapter 1: Introduction
Change has become commonplace in organizations in the United States and
around the world. According to Bordia, Restubog, Jimmieson, and Irmer (2011) and Jaros
(2010), the reasons for this are numerous and include the demands of increasing
globalization and deregulation, the results of mergers and acquisitions (M&As), changes
associated with restructuring or downsizing, as well as the drive to gain competitive edge
and strategic adaptability. These large-scale organizational changes have a significant
potential to disrupt business as usual for organizations, and according to Bordia et al., can
have profound implications for employees. Deeg (2009) also noted that these disruptions
affect organizational performance. Consequently, the study of change initiatives and
change management has become important to business and organizational researchers,
and caused employee response to change to become an important area of research (Jaros,
2010).
Successful change execution requires some understanding of the factors that
predict employee response to change. Multiple researchers such as Goksoy, Ozsoy, and
Vayvay (2012); Herscovitch and Meyer (2002); Lau and Woodman (1995); and Oreg and
Sverdlik (2011), studied employee response to large-scale change in other industries, but
gave little attention to employee response during large-scale change execution in the
pharmaceutical industry. Large-scale change is common in the pharmaceutical industry,
as it is subject to frequent M&As, a type of large-scale change phenomenon Hornke
(2010) and Hornke and Mandewirth (2010) described as a business strategy that
pharmaceutical companies have increasingly used to gain and sustain a competitive
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advantage. Shibayama, Tanikawa, and Kimura (2011) further noted that M&As are one
of the main drivers of change in the pharmaceutical industry and are used as an essential
strategic measure.
Employees respond to change, such as M&As, either by supporting or resisting it.
An instrument for studying employee response to change is the Behavioral Support for
Change Scale (BSCS; Herscovitch & Meyer, 2002). Georgalis, Samaratunge, and
Kimberley (2015) studied the effects of Australian employees’ feelings of justice and
fairness on resistance to change, finding that feelings of justice had a mediating effect on
change resistance. Lysova, Richardson, Khapova, and Jansen (2015) also studied
employee support of change by examining the relationship with career identity, finding
that employees actively engaged in career-seeking behaviors were more likely to display
supportive change behaviors than those who were more passive. Oreg (2003) used the
Resistance to Change Scale to assess whether a person is inclined to resist change. These
approaches are appropriate for understanding employee response to change (i.e., support
or resistance). However, these studies focused on organizations outside the
pharmaceutical industry.
Research into employee reaction and engagement during large-scale change in the
pharmaceutical industry is lacking, in spite of the high-risk nature of the industry and the
consequences of poor change execution. For example, a drug costs $1.8 billion from
discovery to commercialization (Golec, Hegde, & Vernon, 2010). During the course of
this expensive, heavily regulated, and lengthy drug development process, companies
often merge to stay competitive (Shibayama et al., 2011). These mergers create a need for
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effective change management, which makes it important to understand the key factors
that predict employee support of change in the pharmaceutical industry. However, these
factors have not been studied in-depth in the research literature on large-scale
organizational change in the pharmaceutical industry.
This study was designed to understand and document employee reactions that
indicate their level of reaction to change or support of change. Herscovitch and Meyer
(2002) identified three operationalized measures of support of change: compliance
(minimum supportive behavior), cooperation (more supportive), and championing (the
highest level of support). These operationalized measures, along with active and passive
resistance, encompass reaction to change and form the full spectrum of employee
response to change examined in my study. I addressed the lack of knowledge and
understanding about employee response to change by examining whether any of four
factors (initial change reaction, change communication, involvement in change
development, and perceived change success) predict employee response to large-scale
change initiatives. This study was also designed to provide practical information on
employee response to change to inform pharmaceutical managers and associated change
leaders who are planning and implementing change.
In the remainder of this chapter, I will offer the background of the study, state the
research problem and the purpose of the study, lay out the research questions, and outline
the theoretical framework for the study, which is a synthesis of transformational
leadership, stakeholder, and change management theories. I then describe the nature of
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this quantitative, correlational study; offer a definition of key terms and variables; and
address assumptions, limitations, and delimitations of the study.
Background
Pharmaceutical research and development (R&D) is the cornerstone of one of the
most expensive and high-risk global industries, and plays a crucial role in addressing the
world’s present and future health needs. In the global pharmaceutical industry, only one
in 10,000 discovered compounds make it to market (Cook, Hunter, & Vernon, 2009);
because of this, bringing a pharmaceutical compound to market costs an average of $1.8
billion (Golec et al., 2010). Regulatory agencies around the world, such as the United
States Food and Drug Administration (FDA) and the European Medicines Agency
(EMA), also heavily regulate the industry, and pharmaceutical companies must meet
strict requirements before a drug is approved for marketing (Van Doren, 2011; Wechsler,
2009). These challenges create pressure on the pharmaceutical industry to find ways to
operate more efficiently. A common approach in the industry is to engage in M&As as a
key strategic measure that affects multiple processes, employees, and departments
(Hornke, 2009; Hornke & Mandewirth, 2010).
M&As are examples of large-scale change initiatives; all organizations
experiencing large-scale change initiatives must manage them well to avoid negative
consequences. Deeg (2009) observed that change of this magnitude has the potential to
disrupt a company’s performance, success, and growth if not handled effectively and
efficiently. Barcan (2010) echoed this sentiment by elaborating further on the need for an
environment that is conducive to sound decision-making in the pharmaceutical industry.
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The expensive and high-risk nature of the pharmaceutical industry suggests that the largescale organizational changes resulting from mergers and acquisitions have a similar
potential to disrupt not only company productivity and revenue, but also employee
commitment.
Although research exists on employee response to change in other areas of
business and industry, no research exists that specifically identified the factors that
predict employee compliance, cooperation, and championing of change in the
pharmaceutical industry. Goksoy et al. (2012) and Oreg and Sverdlik (2011), for
example, examined the importance of understanding employee response during change
implementation, but not in pharmaceutical industry settings. Therefore, in this study, I
examined whether several factors predict employee support or reaction to large-scale
change initiatives, such as M&As, in the pharmaceutical industry. The specific factors
that I investigated were the following:


change communication,



initial change reaction,



involvement in change development, and



perceived change success.

Employee support was measured in terms of compliance, cooperation, and championing.
Knowledge of these factors is crucial for developing effective change
management strategies that minimize the potential disruptive effects on employees and
business operations. Effective change management is extremely important in the area of
pharmaceutical R&D because of the high stakes involved (Cook et al., 2009). This study
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was designed to address the gap in scholarly research on change management in the
pharmaceutical industry. The results of this study have practical implications for guiding
the creation of a supportive work environment during organizational change—a
transitional environment in which employees are motivated and engaged in their jobs to
meet health and medical needs globally, while the companies create skilled jobs and
generate profit.
Problem Statement
Multiple researchers have sought to understand employee engagement and
response during large-scale change initiatives in nonpharmaceutical industries (Goksoy et
al., 2012; Herscovitch & Meyer, 2002; Lau & Woodman, 1995; Oreg & Sverdlik, 2011).
According to Budhwar, Varma, Katou, and Narayan (2009), 50–80% of M&As fail
because of clashing corporate cultures, a lack of clear communication, and a lack of
employee involvement in the change. However, employee response to change in the
pharmaceutical industry remains understudied and underrepresented. Therefore, the
problem addressed by this study was a lack of scholarly research and understanding of
the factors that predict employee response to large-scale organizational change such as
M&As in the pharmaceutical industry.
Purpose of the Study
The purpose of this quantitative, correlational study was to narrow the knowledge
gap on large-scale organizational change in the pharmaceutical industry by evaluating
key predictors of employee response to large-scale change. The two primary dependent
variables in this research were reaction to change (RC), which includes the full spectrum
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of reactions ranging from active resistance to championing change; and support of change
(SC), which was also expressed as three separate measures: compliance (CM),
cooperation (CP), and championing (CH). The four independent variables were initial
change reaction (ICR), change communication (CHC), involvement in change
development (ICD), and perceived change success (PCS).
Research Questions and Hypotheses
The key research questions and their respective hypotheses were the following:
1. What is the relationship between RC and the predictor variables ICR, ICD,
PCS, and CHC?
H01: No relationship exists between RC and the predictor variables ICR,
ICD, PCS, and CHC.
Ha1: A relationship exists between RC and the predictor variables ICR,
ICD, PCS, and CHC.
2. What is the relationship between SC and the predictor variables ICR, ICD,
PCS, and CHC?
H02: No relationship exists between SC and the predictor variables ICR,
ICD, PCS, and CHC.
Ha2: A relationship exists between SC and the predictor variables ICR,
ICD, PCS, and CHC.
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Theoretical Framework for the Study
The theoretical basis for this quantitative, correlational survey study consisted of a
synthesis of transformational leadership, stakeholder theory, and change management
theory.
Transformational Leadership Theory
Burns (1978) defined transformational leadership as a relationship between
leaders and followers wherein they “raise one another to higher levels of morality and
motivation” (p. 20). Bass (1985) further defined transformational leadership as the
process through which leaders inspire and motivate people based on collective purposes.
Bass also noted that transformational leaders are concerned with a follower’s intellectual
stimulation, while leading through charisma, inspiration, and motivation.
Wang and Rode (2010) studied transformational leadership as a way to effectively
lead change. According to Wang and Rode, transformational leadership involves
encouraging, facilitating, and accepting subordinate interests and input relating to
organizational concerns and decision-making processes. Similarly, Jaros (2010) found
that effective change leadership is crucial to planning, implementing, and managing
successful organizational change.
Stakeholder Theory
Freeman (1984) developed stakeholder theory to describe how to address the
interests of each stakeholder without unfairly valuing some stakeholders over others.
Freeman defined stakeholders as key players or those with stakes in an enterprise, such as
employees, owners, financiers, customers, communities, competitors, and government.
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This theory was developed for use in establishing equity in value creation, trade, ethics,
capitalism, and management's role in dealing with those issues.
Change Management Theory
Change management theory falls under the umbrella of social or organizational
psychology. It incorporates a 3-stage model of the change process in which organizations
move from a position of stasis into a new position or perspective (Lewin, 1947). These
stages of change, according to Lewin, involve unfreezing (the undoing of an established
mindset or approach), actual change (which involves a certain degree of uncertainty
about the future), and freezing (the establishment of a new mindset or position).
Researchers, such as Marks and Mirvis (2011), subsequently used Lewin’s theories of
change and group dynamics in studies of organizational adaptation to change to study the
relationship between cultural differences and M&A outcomes. In response to large-scale
organizational change associated with corporate mergers, evolving business
environments, and increasingly globalized markets, studies began to emerge on how to
manage adaptive and organizational change, some of which used change management
theory as the theoretical framework. Ruta (2005), for example, demonstrated the use of
change management theory in implementation of systems in a multinational corporation.
Nature of the Study
This quantitative, correlational study was designed to explore employee responses
to large-scale organizational change such as M&As. It specifically investigated whether
employees support or resist such change in the context of the pharmaceutical industry. I
obtained data from a random sample of 98 pharmaceutical professionals who had
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experienced large-scale organizational change. I collected data from these participants
using the BSCS and additional, pharmaceutical industry-specific questions; the survey
was administered online, and the survey data analyzed using multiple regression analysis
to measure associations between BSCS factors and change response. Permission to use
the BSCS instrument is in Appendix A. I conducted one linear regression analysis for
Hypothesis 1 and four analyses for Hypothesis 2 (one for each of the individual subscales
for support of change and one for the composite index).
The two primary dependent variables in this study were (a) RC on a 9-point
continuum ranging from active resistance to championing change; and (b) SC, comprised
of three subscales: CM, CP, and CH. Each of the subscales is a dependent variable for
Research Question and Hypothesis 2. For these dependent variables, participants
answered the support of change items associated with each subscale on a 7-point Likerttype scale. I then calculated the mean of these subscale responses and combined them
into a single, composite index that indicates their overall support of change.
The independent or predictor variables were the four predictors hypothesized to
affect the change’s implementation: ICR, ICD, PCS, and CHC. To answer the key
research questions and test the respective hypotheses, I measured the association between
the dependent variables and the four predictor variables.
Definitions
The following key terms and definitions were used in this study:
Active Resistance: Opposing the change through clear and deliberate actions
(Herscovitch & Meyer, 2002).
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Championing: An extreme enthusiasm for change and doing more than is
formally required to ensure change success, and promoting the change to others
(Herscovitch & Meyer, 2002).
Change communication: The manner and frequency that management conveys
information relevant to the proposed change to employees (Herscovitch & Meyer, 2002).
Change communication involves the clarity and quality of communication (good, poor)
as well as frequency (often, infrequently) of communication. In this study, change
communication was measured by averaging the responses to two survey questions related
to communication, creating an overall communication score.
Compliance: Demonstrating minimum support for change by acquiescing to
change, but doing so reluctantly (Herscovitch & Meyer, 2002).
Cooperation: Demonstrating support for change by putting forth effort in change
initiatives and being willing to make modest sacrifices (Herscovitch & Meyer, 2002).
Initial reaction: Participants’ responses when first learning about organizational
change as either negative or positive, ranging from: I will lose my job (negative) to I will
get promoted (positive) (Herscovitch & Meyer, 2002).
Involvement in change design: The degree to which an employee takes part in the
planning and implementation of change (Jaros, 2010). I measured this variable from a
single survey question. The range of involvement on this item runs from very involved to
not involved. Employees may be heavily involved in change design to the degree that
they willingly cooperate, or even champion the proposed change, or employees may be
minimally involved or not involved at all.
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Leadership: A series of transactional events between someone in a position of
authority and their subordinates, or a process in which an individual influences a group of
individuals to achieve a common goal (Bass, 1990).
Management: Allocation and utilization of people and their skills to accomplish
goals. It is “working with and through other people [in organizational settings] to
accomplish the objectives of both the organization and its members” (Montana &
Charnov, 1993, p. 1).
Passive resistance: Subtle, inconspicuous actions intended to oppose a change
(Herscovitch & Meyer, 2002).
Perceived change success: The degree to which employees perceive a proposed
change as completely and effectively implemented (Goksoy et al., 2012). In the context
of this study, this was a study variable measured by a single survey question for which
employees chose their agreement on a scale from a complete failure to a resounding
success.
Assumptions
I assumed that all of the participants involved in this survey had a clear
understanding of and appreciation for the purpose of this study and provided honest,
forthright answers. I supported this assumption by assuring participants of the strict
confidentiality and anonymity of the data and information gathered. I also assumed that
the methodology for this study was reliable and valid, and that the methods of data
collection and analysis were the best options for this study. This is based on Mitchell and
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Jolley’s (2001) discussion of research methods and the appropriateness of the quantitative
design I employed to answer the research questions.
Scope and Delimitations
The scope of this study was limited to pharmaceutical industry employees in the
United States who experienced large-scale change, such as M&As. Although the change
experiences may be similar in other industries, the data may not be generalizable outside
of the pharmaceutical industry. Therefore, readers need to interpret the results with
caution.
Limitations
The study could have been limited by the time allocations and cost of resources
required for the study. The study could also have been limited by the level of efficiency
in collecting and analyzing data; it could have been limited by the level of validity and
reliability in analyzing and reporting data, as well. Participants’ willingness to disclose
information about their perceptions of change and their work environment could have
also limited the study. In addition, several limitations are inherent within the scope of any
quantitative study. Foremost, I used a quantitative method to address the research
questions and hypotheses, but was not able to examine adequately the depth and
underlying detail of some responses. For example, I did not examine those responses
related to the perceptions of all aspects of the change’s implementation as they affect a
participant’s support of the change, and how participants viewed their experience of the
change or what could have been done better. Thus, my study reflects a trade of a degree
of richness within the results for a degree of statistical certainty that associations did not
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occur by chance alone, and an ability to examine the numerical change in these
associations, in accordance with Mitchell and Jolley’s (2001) guidelines.
Significance of the Study
Significance to Theory
The significance of this study lies primarily in its potential to contribute to the
main mission of the pharmaceutical industry: meeting present and future health and
pharmaceutical needs of customers, more effectively realized if managers and change
leaders successfully execute inevitable large-scale organizational change. For example, a
new medical innovation, such as a cervical cancer vaccine, can result in radical changes
to a country’s health policy. Additionally, successful change execution can generate
profit and create jobs. Still, scholarly research on large-scale organizational change in the
pharmaceutical industry from an employee-response perspective is virtually non-existent.
This study, therefore, is not only practically significant for pharmaceutical companies
managing change but theoretically significant as well, since it has the potential to add to
the research literature.
Significance to Practice
A key driver of the significance of this study is the potential to avoid one of the
common negative outcomes of change: the costly consequence of losing talented
employees. In a study of employee turnover, Tracey and Hinkin (2008) noted that
turnover is costlier for higher complexity jobs, such as those in the pharmaceutical
industry, than for lower complexity ones. Based on data from the Bureau of Labor
Statistics, O’Connell and Mei-Chuan (2007) placed the estimated cost of employee
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turnover, averaged for all sectors, at close to $14,000 per employee. O’Connell and MeiChuan further illustrated the potential magnitude of this problem by presenting data,
which showed that the majority of the 24% of employees who quit their jobs annually did
so voluntarily. In the example O’Connell and Mei-Chuan shared, the annual cost of
employee turnover at a company with 1,000 employees is over two million dollars.
Larger pharmaceutical companies typically employ 10,000 to 100,000 individuals.
Therefore, in addition to contributing to the creation of a supportive work environment
where employees can operate at their full capacity, a study such as this has significant
potential to contribute to cost reduction associated with change-related employee
turnover.
Large-scale change initiatives, if executed well, can reinforce an employee’s
commitment to their work and organization. This study is significant because it may
uncover steps pharmaceutical companies can take to minimize distractions during the
inherent discontinuity of organizational change, effectively allowing employees to focus
on executing their work-related responsibilities. This study, therefore, may uncover
useful information not only for clinical professionals, but also for other stakeholders—
owners, patients, communities, and government.
Significance to Social Change
Clinical research professionals at pharmaceutical companies are very much
involved in creating positive social change. Besides creating profit, the intent of a
pharmaceutical company’s R&D efforts is frequently to create medicines that meet health
needs and improve the quality of life of individuals around the world. In some cases, the
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medicines and other scientific innovations are lifesaving, which is the ultimate testament
to the potential effect of the company’s work on social change. Given the substantial
opportunity for social change in this profession, it is important for socially responsible
organizations to create an environment in which pharmaceutical employees can have the
greatest effect on others. The study is significant because it may uncover strategies
organizations can utilize to improve acceptance and support of sound change in the
pharmaceutical industry.
Summary
In this chapter, the focus was on large-scale organizational change in the
pharmaceutical industry, with particular emphasis on employee response to change. I
established, through a thorough review of the literature, that limited scholarly research of
this phenomenon exists, and adapted the BSCS with pharmaceutical industry-specific
questions to conduct the analysis through a survey. I also listed a number of hypotheses
to help assess the associations between four predictor variables (ICR, ICD, PCS, and
CHC) and employee response to change, as measured through two primary dependent
variables (RC on a continuum ranging from active resistance to championing change; and
SC operationalized through the level of compliance, cooperation, and championing of
change).
Chapter 1 was a succinct review of the key elements of the study and constituted
the foundation to build on in future chapters. Through a synthesis of transformational
leadership theory, stakeholder theory, and change management theory, I established the
theoretical framework for the study. I also discussed key assumptions, scope, and
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limitations in Chapter 1. Chapter 2 examines these three theories in more depth, including
an explanation of how other researchers used these theories. I further construct a logical
argument laying out the rationale for this study with emphasis on key drivers of
pharmaceutical industry change, the expensive and high risk nature of the industry, and
the potential contribution to positive social change. In Chapter 3, I provide a detailed
description of the methodology to select research participants, collect, and analyze the
data using multiple regression.
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Chapter 2: Literature Review
This quantitative, correlational study was designed to measure employees’
responses to large-scale organizational change within the pharmaceutical industry. While
researchers such as Goksoy et al. (2012) and Oreg and Sverdlik (2011) studied employee
response to change in other industries, this phenomenon has not previously been explored
in the pharmaceutical industry. The study of change management and employee response
to change is crucial in the pharmaceutical industry, which is subject to large-scale
organizational change caused by federal regulations, market trends, and M&As (Hornke
& Mandewirth, 2010; Mehralian & Shabaninejad, 2014; Saranga & Banker, 2009;
Vernon, Golec, & Stevens, 2010).
This chapter consists of a review and synthesis of relevant literature and studies.
The objective of this review was to critically analyze current change management
literature on employee response to change, with the aim to identify and describe a gap in
scholarly research on this phenomenon in the pharmaceutical industry. This review is
framed by a theoretical framework consisting of change management theory, stakeholder
theory, and transformational leadership theory, which are also examined in detail. I
further investigate the overall context of this study by reviewing studies on employee
support of and involvement in organizational change, and the major drivers of change in
the pharmaceutical industry.
Literature Search Strategy
I obtained the literature for this review through comprehensive online search
methods. I searched various combinations of the following key terms and phrases:
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pharmaceutical merger, pharmaceutical industry change, effect of change on employees,
employee response to change, large-scale pharmaceutical change, management and
change, and leadership and change. I primarily used Academic Search Complete and
Business Source Complete to search for relevant and current, peer-reviewed journal
articles, five or fewer years old. I also searched Walden University’s online library using
Google Scholar to obtain additional full-text articles for this review. Finally, I obtained
the titles of several additional studies listed in the bibliographies of key studies on
organizational change.
Theoretical Framework
Change Management Theory
Change management theory falls under the umbrella of organizational and social
psychology and is associated with Lewin’s (1947) ideas on change processes and group
dynamics. Lewin, who is often recognized as the founder of social psychology,
developed a 3-stage model of the change process that describes moving from a position
of stasis into a new position or perspective. These stages of change consist of unfreezing
(the undoing of an established mindset or approach), actual change (which involves a
certain degree of uncertainty about the future), and freezing (the establishment of a new
mindset or position). Researchers, such as Marks and Mirvis (2011), later used Lewin’s
theories of change and group dynamics in studies of organizational adaptation to change.
In response to large-scale organizational change associated with corporate
mergers, evolving business environments, and increasingly globalized markets, studies
began to emerge on how to manage adaptive and organizational change. Ruta (2005)
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utilized change management theory to study implementation of a human resource system
at various subsidiaries in a multinational corporation. More recently, Deeg (2009) noted
that because of its ubiquity and inevitability, large-scale change represents potential
organizational discontinuity and, consequently, effective change management has
become a major component of organizational success. The pharmaceutical industry is
especially subject to organizational discontinuity related to large-scale change (Hornke &
Mandewirth, 2010; Mehralian & Shabaninejad, 2014; Saranga & Banker, 2009; Vernon
et al., 2010). Therefore, examining studies on change management were appropriate for
contextualizing and framing this study.
Transformational Leadership Theory
Transformational leadership is often associated with successful major change.
Burns (1978) defined transformational leadership as a relationship between leaders and
followers wherein they “raise one another to higher levels of morality and motivation” (p.
20). Bass (1985) also defined transformational leadership as the process through which
leaders inspire and motivate people based on collective purposes. Wang and Rode (2010)
studied transformational leadership as a way to effectively lead change. According to
Wang and Rode, transformational leadership involves encouraging, facilitating, and
accepting subordinate interests and input relating to organizational concerns and
decision-making processes. Similarly, Jaros (2010) found that effective change leadership
is crucial to planning, implementing, and managing successful organizational change. As
a bottom-up approach, transformational leadership has the potential to engage employees
in the change process because Jaros and Whelan-Berry and Somerville (2010)
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demonstrated that employee engagement is a key factor in implementing successful
organizational change. Therefore, transformational leaders often bring about desired
effects through inspirational motivation, personal charisma, and by considering and
motivating followers.
Stakeholder Theory
Stakeholder theory was also used as part of the theoretical framework for this
study. Researchers generally credit the origins of stakeholder theory to R. Edward
Freeman’s 1984 foundational text Strategic Management: A Stakeholder Approach.
According to Freeman, stakeholder theory is concerned with issues involving key players
or those with stakes in an enterprise (i.e., stakeholders): employees, owners, financiers,
customers, communities, competitors, and government entities. Freeman used this theory
to question the traditional idea that one stakeholder (such as an owner) is automatically
more valued than all others are. In a business environment where the main motivation is
to make a profit, owners (including shareholders) have been seen as the primary
stakeholder, and many business decisions are made based on the interests of this
particular stakeholder. However, Freeman argued that the interests and concerns of other
parties involved, with stakes in an enterprise, should matter as well when making
business decisions. According to the theory, this inclusive approach creates ownership
and a sense of belonging for those involved. Like transformational leadership,
stakeholder theory relies on a bottom-up approach that has the potential to engage crucial
stakeholders, such as employees, in the change process.
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Key Variables and Concepts
Employee Involvement in and Support of Change
Employee commitment to and support of change has been the subject of extensive
research. Lau and Woodman (1995) examined the causes rather than the consequences of
change commitment. Jaros (2010) and Whelan-Berry and Somerville (2010) asserted that
effective organizational change management is crucial to how organizations successfully
handle large-scale change, and employee participation in and support of change are key
factors in successful change initiatives. Jaros (2010) also found that getting employees to
commit to new procedures, policies, and goals involving change increases the likelihood
of change success. This commitment implies that employees will support the change.
Employee response to change is multidimensional. It involves behavioral and
attitudinal components (Jaros, 2012) as well as emotional ones (Mishra & Bhatnagar,
2010), including feelings of ambivalence (Oreg & Sverdlik, 2011). Therefore, I
approached employee involvement in change as a multidimensional construct, similar to
the approach Herscovitch and Meyer (2002) took. According to Herscovitch and Meyer,
Compliance, cooperation, and championing encompass the range of employee support
from minimal support of change to enthusiastic promotion or championing of change; the
negative aspects of response to change, active and passive resistance, complete the
continuum of reaction to change.
Recent studies have shown that the manner and the degree to which employees
are included in change implementation enhances their organization’s successful transition
to a new working reality. For example, Franckeiss (2012) used a case study approach to
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explore change management at a traditional print-based global publishing company fully
preparing to embrace digital-age publishing and to implement changes relating to online
publication and delivery systems. Franckeiss found that preparing employees for the
change through hands-on inclusion techniques caused them to support change
implementation and increased the change success. The inclusive, hands-on techniques
examined included workshops on leading, implementing, and experiencing the dynamics
and expectations of change, as well as pre- and postevent webinars with follow-up
activities. Although Franckeiss’s study was qualitative and examined a different industry,
it had important implications for this research because it showed that employee
involvement and inclusion in organizational change increases support for and successful
implementation of change.
Researchers and practitioners have also studied and devised formalized
approaches to change management in recent years, also highlighting the importance of
employee involvement. For example, Goksoy et al. (2012) studied business process
reengineering (BPR) as a strategic tool for managing radical organizational change
intended to improve an organization’s performance. According to Goksoy et al., BPR is
“the fundamental rethinking and redesign of business processes to achieve dramatic
improvements in critical, contemporary measures of performance, such as cost, quality,
service, and speed” (p. 92). High-profile corporations such as Taco Bell, Kodak, IBM
Credit Corporation, and Hallmark have successfully employed BPR to improve their
existing business conditions and maintain a competitive advantage. Because BPR has
become a popular change management approach, Goksoy et al. sought to test and analyze

24
BPR as a prominent management trend for organizational change as it applied to a
multinational electronics and electrical equipment company in Turkey. Goksoy et al.
empirically analyzed survey responses of 155 employees and found that the key success
factors of BPR included (a) proper and careful implementation, (b) commitment and
support from management in terms of resources and leadership, (c) communication, (d)
teamwork, and (e) adherence to the overall reengineering or change strategy. The
Cronbach Alpha Internal Consistency Co-efficient came out to 0.8768, indicating that the
reliability and internal consistency of their five-point Likert scale consisting of 10
variables were high. The researchers recommended collection of information from
management and change agents, as well as employees, to obtain accurate information
about BPR. Although the researchers focused on a global electronics company, the issues
addressed are applicable to the pharmaceutical industry as well. For example, product
lifecycles in electronic companies may be short, but pharmaceutical companies must
constantly focus on innovation because of the long development timeline needed to bring
medicines and therapies to consumers. Therefore, pharmaceutical companies may need to
adopt BPR practices to improve operational processes so they can maximize patent life to
recoup drug discovery and development expenses for profit. Also relevant to my study is
that the researchers also found employee involvement in the change process through
teamwork and change communication to be key success factors of change management.
Change Communication
Communication is an integral part of organizational change, as it is the means of
disseminating information to stakeholders and receiving feedback. Goksoy et al. (2012)
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and Whelan-Berry and Somerville (2010) found that clear communication of change is a
key component of effective and successful change. Goksoy et al. (2012) found that 48%
of employees surveyed perceived communication with them before and during BPR
change implementation to be the overriding success factor of BPR change. In their review
and analysis of recent organizational change literature, Whelan-Berry and Somerville
(2010) found that communication was the most identified variable associated with both
change success and failure. Whelan-Berry and Somerville found that positive
communication is linked with successful change, and poor communication led to change
failure. They also noted that regular and clear communication was important throughout
the entire change process, starting even before initiating the actual change process.
Whelan-Berry and Somerville further stated that employees’ understanding of the need
for change in the first place was crucial, as was communication on both individual and
group levels throughout the change process. In addition, Whelan-Berry and Somerville
found that good communication was important for both employee adoption and support
of change.
Other Key Concepts
The role of change leaders and human resources. Change leaders might
overlook the resource requirements and monitoring needed during change
implementation. In their theory-building meta-analysis, Whelan-Berry and Somerville
(2010) examined the link between major drivers of change and the organizational change
process. The researchers observed that while change leaders of an organization may have
a clear vision of change, they might not have considered whether the organization was
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ready for change. They further observed that change leaders often did not consider how
they might measure successful change afterward. Whelan-Berry and Somerville
contended that while organizational change can be challenging and complex, it is also
mapable and foreseeable. Whelan-Berry & Somerville isolated four key contributors to
successful change: (a) a clear vision of change; (b) leaders’ change-related actions; (c)
change-related communication, training, and employee participation; and (d) aligned
human resources practices and organizational structure and processes. Their theorybuilding article contributed to the research literature by identifying major factors of
change and discussing how they relate to the change process in order to manage
organizational change more effectively. Furthermore, Whelan-Berry and Somerville
found that adequate change planning is crucial for successful change, and that many
change efforts fail from lack of adequate resources and planning. They also concluded
that it is important to use a mix of change drivers across the key steps of the change
process. This article is important and relevant to my study because it has a link
demonstrating that employee participation in change is a key factor in effective and
successful change management, although none of the settings involved the
pharmaceutical industry.
Researchers have also studied the key roles that human resource managers can
take on as change agents in change implementation and management. For example, using
a mixed-methods case study approach grounded in Gidden’s structuration theory, BarrattPugh, Bahn, and Gakere (2013) studied organization change associated with the merger
of two dissimilar state government departments in Western Australia. Their study
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exemplified how human resources departments facilitated and managed change
implementation through various mechanisms. The researchers conducted the study in
three phases, starting with a survey of 2,000 employees and ending with interviews of
employees and of 30 state government executives. Managers used various formal and
informal agents of change techniques to encourage support for change. The researchers
found that the mode of change management influenced employee experiences of change:
positive experiences resulted from informal, relational techniques, while negative
experiences largely resulted from more formal, authoritative managerial techniques. The
state departments had selected human resource managers based on technical expertise
rather than on relational skills, so when change arrived, managers did not have the
relational or teambuilding skills to effectively usher their teams down new paths.
Consequently, Barratt-Pugh et al. recommended that human resource departments take a
strategic approach to change, one that facilitates change by supporting teamwork as
organizations work through change and emphasizes relational leadership capabilities in
human resource managers in addition to formal technical skills. Like the findings of
Goksoy et al.’s 2012 study, the findings of Barratt-Pugh et al.’s study suggested that
employee involvement in the change process through teamwork was a key success factor
of change management. Furthermore, the study had valuable practical information on the
kinds of informal relational skills needed by human resource managers to manage
effective organizational change.
The role of transformational leadership. Researchers have studied the
connection of transformational leadership to individual adaptive change and
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organizational innovation. For example, in their correlational study, Charbonnier-Voirin,
El Akremi, and Vandenberghe (2010) hypothesized that transformational leadership is
the type required to facilitate individual adaptive performance, as well as a climate of
organizational innovation through teamwork. The researchers recognized that
transformational leadership may work on both individual and team levels. They used
hierarchical linear modeling to analyze data collected from 120 employees and managers
of an aerospace industry organization. Their findings confirmed their predictions that a
positive link exists between transformational leadership and individual adaptive
performance and a climate of team-level innovation. Practical implications included
developing leadership practices that encourage self-management and fosters acceptance
of team-based decision-making and group goals.
Researchers also examined transformational leadership and follower creativity as
they relate to organizational climates of innovation and change. Wang and Rode (2010)
looked at transformational leadership in relation to how well employees identified with
their leadership and how supportive of innovation the organization was in relation to its
employees. They found that the interaction of all three parameters (leadership style,
climate of innovative, and identification with leader) fostered employee creativity. The
researchers focused on a large number of organizations across multiple industries,
including pharmaceutical companies. Pharmaceutical company employees must follow
strict protocols to comply with a multitude of regulations associated with research
involving human subjects. However, tremendous room exists for creativity and
innovation relating to process improvement to accelerate drug development. Therefore,
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change management practices that support the interaction of these three elements could
have a positive effect on employee reaction to change in the industry. There remains an
opportunity to optimize change management effects in an innovative, transformational
leadership environment, where employees identify with leaders.
Researchers have also studied transformational leadership as it relates to change
management in areas related to the pharmaceutical industry, such as nursing. In one
example, Ricke-Kiely and Robey-Williams (2011) explored how transformational
leadership could be used to guide and manage change at a South Carolina hospital. The
researchers used a qualitative research design to gain insight from a sample of nurses
during a Magnet recognition program, which ran from 2003 to 2005. Magnet recognition
was a credentialing status designed to attract, recruit, and retain quality nurses. Thirtyfive nurses participated in focus groups. Of the 35 nurses, six were managers, 34 were
female, and one was male. Over half of the participants achieved at least a bachelor of
science in nursing degree and the median experience of the group was 20 years. The
researchers based their theoretical framework on Kotter’s (1996) change model and the
attributes of transformational leadership. Three major themes concerning the perceived
change of the hospital emerged from analysis of the data collected: recognition,
resources, and culture. All participants were aware of the prestigious value of the Magnet
award, and they all identified recognition as the primary result of it. However, nurse
managers and staff disagreed on resources. Managers thought the hospital had become a
more attractive place to work resulting in less over-time expenses, while staff thought the
Magnet recognition had little or no effect on resources. Changes in culture were less
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noticeable, as staff expected something radical to happen that did not happen, while nurse
managers saw incremental change associated with research, retention, and increased
overall quality. Although the study provided valuable information on how employees of
differing levels perceive change and its consequences, a key limitation of this study was
that other important stakeholders, such as patients, physicians, and family members, were
not included in the sample. These stakeholders could have provided useful insight about
their experiences and perceptions of change. Additionally, a pre-Magnet survey would
have also served as a good baseline comparison.
The role of change management. Change is a staple in today’s organizations.
According to Jaros (2010), as markets became more global, competitive, and deregulated, change has become the norm for many organizations and businesses. Jaros
observed that the globalization and de-regulation of markets, for example, require
competitive and strategic adaptability on the part of businesses and organizations,
adaptability that often necessitates the implementation of new goals and change
initiatives. More and more, organizations must respond to dramatic changes in operations
and structure, such as those resulting from M&As, in order to remain viable and
competitive (Deeg, 2009; Hornke & Mandewirth, 2010). In this regard, the
pharmaceutical industry, in which M&As are seen as essential strategic maneuvers
(Shibayama, Kunihiro, & Kimura, 2011), is no exception. Furthermore, laws and
regulations involving medicines also affect change in the pharmaceutical industry
(Vernon et al., 2010; Whelan-Berry & Sommerville, 2010). Consequently, research on
how organizations and their leaders implement and manage change has become
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increasingly important according to Deeg (2009), Jaros (2010), and Whelan-Berry and
Sommerville (2010). Although researchers have studied organizational change, change
management, and employee response to change in the business sector for the past 20 to
25 years, work on organizational change, change management, and employee
involvement in change has only recently begun to emerge in relation to the
pharmaceutical industry. Budhwar et al. (2009), Jaros (2010), and Whelan-Berry and
Sommerville (2010) are examples of researchers who have done work in the industry.
Therefore, I will review current peer reviewed studies on change management outside the
pharmaceutical industry and discuss how they relate to my study on large-scale
organizational change in the pharmaceutical industry.
Based on recent research, the change management history of an organization and
its employees’ previous experiences of organizational change affect future change
management and change implementation. Bordia, Restubog, Jimmieson, and Irmer
(2011) observed that change management research has, for the most part, overlooked the
role of an organization’s change management history in shaping employee attitudes. The
researchers studied the effects of prior change management on employees’ attitude
toward change and proposed that prior experience with change influences how employees
react to new changes. They also proposed that individual change-related experiences and
the organizational change history of an organization would have significant consequences
for developing change-related attitudes in employees. In their correlational study, Bordia
et al. hypothesized that an organization’s poor change management history (PCMH)
related positively to PCMH beliefs in employees. The authors’ position, based on a socio-
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cognitive model, confirmed that prior change experience influenced employees’ reaction
to change. Findings from interviews and surveys of employees of a Philippine property
and development firm confirmed Bordia et al.’s hypothesis that employees who
experienced poor change management in the past are inclined to react poorly to new
changes. More specifically, the researchers found that PCMH led to decreased openness
to change, job satisfaction, and trust, as well as to increased cynicism and turnover
intentions. The findings of this study have significant implications for the pharmaceutical
industry. The frequency of organizational change in the pharmaceutical industry suggests
that there is a good chance pharmaceutical employees and companies have experienced
or will experience change, making the consideration of PCMH on individual and
organizational levels important to change implementation and management.
Understanding of organizational change and employee response to it remains an
area for further study, especially in the pharmaceutical industry. Deeg (2009) observed
that although change was receiving greater critical and scholarly attention, limitations and
deficits in the conventional discourse on organizational change were still present.
Limitations and deficits in the discourse included lack of theoretical sophistication, lack
of realism, and lack of integration. Deeg argued that existing understandings and models
of change posit change as incremental and gradual, wherein organizational response is
modelled on adaptation and reaction. Current discourse on change also often
characterized change as malleable and predictable, rather than more realistically as
volatile, sharp, sudden, and radical. Furthermore, Deeg’s study of organizational change
suffers from “paradigmatic plurality” (p. 197), a lack of integration, a fragmentation of
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dispersed discourses leading to difficulties in finding what theories, concepts, and models
might have in common. To address these limitations, Deeg forwarded a comprehensive or
integrated model of organizational discontinuity, an approach that encompassed various
research directions and provided a framework that better mirrors the complexity and
plurality of organizational discontinuity. For Deeg, this integrated approach did not
necessarily translate to mere eclecticism, but allowed various theories and insights
through its inclusive character to find their place in the broader scheme systematically.
Deeg’s contribution was highly theoretical, and researchers and practitioners have yet to
test his theory or put it into practice.
Others have examined change in complex, less-structured environments. Pellissier
(2011) discussed the complex nature of innovation and change management from an
organization’s perspective, specifically when implementing change in complex systems
such as those of developing economies. Like Deeg (2009), Pellissier (2011) noted that
linear change solutions inevitably missed the mark because it is difficult to predict
outcomes with so many variables involved. Pellissier argued that developing economies
require non-linear solutions more so than mature economies because the nature of and
interplay between variables in developing economies are more unstable. Additionally, the
organic nature of competition (wherein change associated with competition is taken as
the norm and accepted as practice) calls for non-linear solutions. Pellissier advanced the
concept of resilience engineering as a nonlinear innovation model that went beyond
simply reporting data to delivering insights and projections that support innovation in
technology and change management in complex systems. Again, however, like Deeg
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(2009), Pellissier’s (2011) contribution was theoretical, and researchers and practitioners
have yet to test his theory or put it into practice.
Employees as stakeholders. In short, firms need stakeholders to exist. Parmar et
al. (2010) and Duckworth (2014) identified employees as integral to a firm’s existence.
Duckworth argued that seeing employees as stakeholders can help organizations increase
social responsibility and achieve performance improvement. As stakeholders, employees
are greatly important to an organization’s sense of social responsibility because
organizational decisions and actions, including decisions and actions regarding change,
intimately affect them. Furthermore, stakeholder engagement and identification are keys
to social responsibility because of issues concerning compensation, employment security,
and skill development. Consequently, seeing employees as integral to a firm’s existence,
as stakeholders, may reinforce employees’ participation in change endeavors, which Jaros
(2010) and Whelan-Berry and Somerville (2010) found is a key factor to successful
organizational change implementation. In other words, employees may have an interest in
organizational change not only as employees (how the change will affect their day-to-day
operations), but also as stakeholders (the overall effect of change on the organization’s
success and well-being).
Researchers also recently used stakeholder theory to examine organizational
change based on the need for organizations to transition to more sustainable paradigms.
For example, Valente (2010) noted the struggles of moving from a techno-centric change
management paradigm focused on business behavior to one that is more inclusive, which
considered multiple stakeholders associated with individual businesses. Valente sought to
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understand why after 14 years of advocacy from management researchers for a paradigm
shift, the field of management has not been able to shift from a techno-centric paradigm.
Valente further sought to understand what was required to move toward an alternative
paradigm. Valente employed critical systems theories to develop a 3-phased process
model that advocated a more comprehensive approach, which considered the
interconnectedness of social and economic factors, as well as associated stakeholders of a
particular business targeted for change. The implications of Valente’s framework are
twofold. First, it addresses interconnectedness of social, economic, organizational, and
ecological issues. Second, it recognizes the effects that multiple and diverse agents with
little authority can have on change. Although the model does not focus on employees,
researchers can consider employees as an important part of the interconnected network of
agents that influence change processes.
Others approached the study of stakeholder theory from the perspectives of social
capital, sustainability, and trust. For example, Russo and Perrini (2009) investigated the
differences in approach to corporate social responsibility (CSR) and treatment of
stakeholders based on the size of the organization (large or small to mid-sized). They
found that larger organizations focused more on stakeholder theory, while small to midsized organizations focused on building social capital. Russo and Perrini noted that CSR
has evolved into a service objective of organizations with a genuine interest in doing
good for the communities in which they operate.
In a related article, Garvare and Johansson (2010) developed a model to help
understand stakeholder management from both an organizational and globally
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environmental perspective. Their model shifted focus from simply ensuring the
organization’s product is the best it could be for customers to ensuring a good working
environment for employees as well. They expanded the stakeholder management concept
to include not only employees’ concerns, but to limiting damage to the environment in
which the organization operates as a way to create sustainability, as well. Greenwood and
Buren III (2010) argued that organizations have an ethical obligation to treat their
stakeholders fairly, but that less powerful stakeholders are at risk of unfair treatment.
Greenwood and Buren III discussed the importance of trust in relationships between
organizations and their stakeholders. They noted that organizations strive to ensure that
stakeholders, such as board members and investors who make significant contributions to
the organization’s financial success, are treated well. Other stakeholders, such as junior
employees whose contributions may not be as closely and directly linked to the
company’s success, can be neglected, unless the organization is considered trustworthy.
Greenwood and Buren III’s study has implications for employee involvement in change
because it suggested that at lower hierarchical levels, important contributions employees
make to a change’s success may be neglected or may be missed entirely.
Sustainable organizational change requires a balanced approach that
acknowledges stakeholder needs. Change that focuses exclusively on the traditional
bottom line of reducing cycle time and operating cost, while increasing productivity and
revenue for the business at the expense of stakeholder concerns and social responsibility,
may not facilitate an organization’s sustainable future (Garvare & Johansson, 2010).
Representing the views and concerns of a select group of stakeholders when considering
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and managing change, neglects the needs, concerns, and efforts of other stakeholders,
including employees (Parmar et al., 2010). Organizations, therefore, must consider
influences beyond the immediate business needs of the organization and commit to a shift
towards more responsible business practices that balance economic drivers with social
and environmental objectives, according to Garvare and Johansson (2010). This shift is
necessary for sustainable development implementation, as organizations focus on the
system as a whole and not just the manifestations of the underlying business struggles
(Valente, 2010). Recent studies (Duckworth, 2014; Parmar et al., 2010; Valente, 2010)
indicate that such a shift has begun, but without consideration of the multiple
stakeholders and relationships typical of a complex system, this shift to more socially
conscious change management is not likely to continue.
Emotional dimensions to employee commitment to change. There appears to
be an emotional dimension to employee engagement with organizational change.
Recently, Mishra and Bhatnagar (2010) studied the link between emotional dissonance
and organizational identification to turnover intention and emotional well-being in the
Indian pharmaceutical industry. Mishra and Bhatnagar collected data via a questionnaire
for their correlational study about the emotional conflicts of 486 pharmaceutical
representatives in the Indian pharmaceutical industry. They characterized this emotional
dissonance as the difference between the sales representatives’ true feelings and the
positive expression the representative must display to customers even if the
representative’s true feelings are negative. Through hierarchical regression analysis, the
researchers found that this emotional conflict, or dissonance, was a predictor of employee
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turnover intentions. In addition, they found that an employee’s need to display potentially
opposite emotions about what they were feeling was a significant source of employee
dissatisfaction. They also found that organizational identification and commitment were
not always matters of outright support or resistance, and that organizational identification
and commitment to change are complex and sometimes ambivalent. However, Mishra
and Bhatnagar did not conduct the study in the context of large-scale organizational
change, and focused on organizational identification instead of commitment to change.
The researchers also did not address whether emotional dissonance of pharmaceutical
representatives was greater in the Indian pharmaceutical industry compared to those in
western countries. Nonetheless, the study was important for measuring organizational
identification in employees in the context of the pharmaceutical industry in general.
Sometimes employees do not have strong opinions about organizational change,
and their responses could be misinterpreted. Oreg and Sverdlik (2011) noted that failing
to consider ambivalence can lead to misrepresentation of employees’ reactions to change.
In addition, they noted that employee reaction to change is not unidirectional, and
employees’ feelings about management can influence their reaction to change. For their
correlational study, the researchers reanalyzed data from three previous studies on how
employees felt about organizational change and what change agents affected whether
employees supported or resisted change. Oreg and Sverdlik found that employees can
both resist and support aspects of the same change and that those employees’ personal
attitudes toward change interact with their attitudes toward the change agent, which can
result in ambivalence. In fact, the researchers found that employees with a positive

39
impression of the change agent could still be ambivalent to organizational change. Oreg
and Sverdlik’s study was important because it found that by accounting for ambivalence,
researchers could offer more nuanced explanations of employees’ responses to change.
Drivers of Change in the Pharmaceutical Industry
Mergers and Acquisitions
M&As are common in the pharmaceutical industry. Hornke (2010) and Hornke
and Mandewirth (2010) noted that M&As have become a global phenomenon and
business strategy pharmaceutical companies increasingly use to gain and sustain a
competitive advantage. According to Shibayama et al. (2011), M&As are one of the main
drivers of change in the pharmaceutical industry and are evolving as an essential strategic
measure. In an industry where heavy investment of time and money is required to bring a
promising drug from the laboratories to market, pharmaceutical companies engage in
various business practices to reduce competition (Granier & Trinquard, 2010). According
to Granier and Trinquard, established pharmaceutical companies often address
competitive threat by merging with new entrants to the industry. Shibayama et al (2011).
noted that mergers create significant logistical issues associated with bringing two
organizations together. Lipworth, Montgomery, and Little (2013) further found that
mergers have significant effects on practices and procedures that affect employees, while
Lukkari (2011) found that mergers also affect external considerations, such as customer
relationship management. These large M&As typically require excellent change
management implementation to ensure smooth, successful, and cost-effective transitions,
according to Hornke and Mandewirth (2010).
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A merger significantly affects the logistical issues associated with bringing two
similar organizations together and on practices and procedures that affect employees.
Budhwar et al. (2009) observed in their study of Indian pharmaceutical firms that not all
M&As are successful. They focused on the role of the human resource department in
managing change associated with cross-border M&A processes and why M&As fail.
According to Budhwar et al., 50-80% of M&As fail because of clashing corporate
cultures, a lack of clear communication, and a lack of employee involvement in change.
They noted that the human resources department of both companies involved must be
responsible for three critical factors: (a) the blending of organizational cultures, (b)
facilitating effective communication, and (c) involving employees in the change process
(Budhwar et al., 2009). Using a case study approach, Budhwar et al. examined three
major cross-border M&As and interviewed senior executives, human resource
department heads, and team members of the companies involved. The findings of the
study largely confirmed the findings of the previous literature outlined above. Because of
this, Budhwar et al. recommended further integrative study of the role of human
resources departments in all three stages of the M&As process: pre-integration,
integration, and unification. Budhwar et al.’s study was important for its cross-border
focus. Because M&As occur on a global scale, study of cultural differences as they
pertain to organizational operations and employees during change is increasingly
important. Although this article focused on Indian pharmaceutical companies, it also
highlighted the crucial nature of issues concerning cultural differences and their effects
on employees.
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Marks and Mirvis (2011) also studied the relationship between cultural
differences and M&A outcomes. Marks and Mirvis observed that the top priority in the
M&A process is getting the financial component of the deal right, while adhering to
applicable regulatory requirements. In the pharmaceutical industry, the pipeline of
products is next in the line of priorities, while “softer” cultural issues, noted Marks &
Mirvis (p. 873) have ranked low on the priority list. Consequently, they created a
framework that integrated culture as a core consideration in the M&A process. They
proposed the framework to assist human resources departments in managing issues
associated with acculturation in the M&A process. For this framework, the researchers
used change management theory and highlighted the value of organizations devising a
clear “cultural endstate” (p. 859). The four distinct cultural endstates included (a)
pluralism (partner companies co-exist), (b) integration (partners blend current cultures
together), (c) assimilation (one company absorbs the other), and (d) transformation
(partner companies merge key elements and adopt new norms and values). Marks and
Mirvis used classic change management theory to propose that human resources must
unfreeze extant cultural mind-sets to move people toward the desired cultural endstate,
and then refreeze the desired culture. However, the researchers observed that a company
should note, early in the M&A process, which entity will take a dominant role in which
aspects of the merged organization. Such an approach to M&A-related change could fast
track and could optimize the desired cultural endstate, which is important to a successful
M&A.

42
In another study of change, M&A, and organizational culture, Shibayama et al.
(2011) examined the management of organizational change associated with the case of
the M&A process of two Japanese pharmaceutical companies, which led to the formation
of Astellas Pharmaceutical. Shibayama et al. identified that although previous research
literature focused on M&A cases in Europe and the United States, studies on M&As in
Asia were less common. For their case study, Shibayama et al. drew on information
obtained from in-depth interviews of 10 major players involved in the M&A process,
including members of senior management. The authors found that the merger was
successful because both companies used a hybrid model of change management that
employed both a top-down approach led by a core team of managers, as well as a
bottoms-up approach supported by employees at all levels of the organization, including
the lowest. They noted that while there were inefficiencies associated with inclusion of so
many employees at a low level of the organization, the inclusive approach fostered great
support for the implemented changes. In addition, the chief executive officers (CEOs) of
both companies established a relationship of mutual trust that they strengthened and
sustained throughout the merger process. This study, like others (Barratt-Pugh et al.,
2013; Budhwar et al., 2009; Franckeiss, 2012; Goksoy et al., 2012; Marks & Mirvis,
2011; Whelan-Berry & Sommerville, 2010), also found that employee involvement in
change is a key factor in implementing successful change.
Large-scale change needs good coordination, as they typically affect multiple
departments. In an article on the connection between internal culture change and
governance policy, Radwan (2010) discussed how large-scale change initiatives, such as
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those associated with mergers, affect multiple departments in large organizations,
requiring a coordinated whole system approach. According to Radwan, this whole system
approach entails examining the change from multiple angles. First, change managers
must consider the actual entity requiring change, along with the associated objectives.
Next, change managers must consider the process of getting from the current state to the
desired state. Last, change agents must understand the provisions to put in place to
support these two previous components of organizational change. All this, Radwan
argued, requires a whole system approach that may obligate significant change to an
organization’s governance policy.
Research and Development, Regulations, and Economics
Pharmaceutical regulations change constantly and the industry must respond.
According to Whelan-Berry and Sommerville (2010), these regulations are major drivers
of change in the pharmaceutical industry and include research and development (R&D)
guidance to industry and the regulation and marketing of new and existing products.
Changes in drug regulations can affect R&D and marketing decisions, as well as
organizational responses leading to change, such as M&As, and offering new lines of
products (Cook et al., 2009). For example, established pharmaceutical companies
sometimes address competitive threat by producing generic versions of their competitor’s
products (Granier & Trinquard, 2010). In addition, considering the enormous amount of
time and money required to bring new drugs to market, pharmaceutical companies must
sometimes act on predicted and forecasted product trends, regulations, and market
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effects, according to Cook et al (2009). This balanced approach is a way to mitigate the
risk of regulation change while remaining competitive.
The pharmaceutical industry is also sensitive to new laws and can undergo major
change as a result. Golec et al. (2009) addressed how government regulations, even
anticipated ones, could dramatically affect R&D activity in the pharmaceutical industry.
In this article, Golec et al. reviewed the effect of President Clinton’s announcement of
pharmaceutical price controls through the Health Securities Act (HSA) on stock prices of
select pharmaceutical firms. Although the act did not actually pass, significant reductions
in R&D investment and corresponding reductions in stock prices occurred. For example,
while new drug applications (NDAs) remained steady following the announcement of
HSA in 1992, the number of new investigational drug applications (INDs) fell sharply
and leveled off before rising again in 1995, following the rejection of HSA. This meant
that pharmaceutical companies were afraid to invest in R&D related to innovations. This
reduction in spending is understandable, as firms count on the expected right to charge
for the years of risk they take on to discover and develop medical innovations.
Consequentially, pharmaceutical companies respond quickly to any threats to the
company’s ability to recoup such investments, as seen in this study.
Changes in sample size requirements and types of research studies also drive
change in the industry. Vernon et al. (2010) reviewed the effect of comparative
effectiveness research (CER) on innovation in light of the Health Care Reform Act. They
noted that CER is rigorous, and typically involves large samples intended to show that
the drug or other medical innovation actually made a clinically meaningful difference and
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resulted in more efficient and cost effective healthcare delivery. Vernon et al. estimated
the cost of bringing a drug to market at $1 billion, with some estimates even higher, and
CER usually occurs during phase III clinical trials, where nearly one third of drug
development expenses reside (Puig-Junoy, 2010; Scheffer & Kaeb, 2011; Vernon et al.,
2010). Such new requirements add to the already high cost of drug discovery and
development, placing more pressure on pharmaceutical companies to effect change in
order to perform well in an ever-changing industry.
Others have examined the high-risk nature of drug discovery and development.
Cook et al. (2009) reviewed the high cost of drug development and detailed the low
percentage of potential drugs that actually make it to market. They also discussed the
potential value of pharmaceutical innovations, such as pharmacogenomics (using
genomic markers to predict drug response), in not only reducing the cost of drug
development, but also effectively laying the groundwork for increased revenue from
longer patent life associated with faster development timelines. The researchers noted
that a drug could take more than 12 years from initial investment at the discovery stage
for it to appear on the market and costs over $1.3 billion. Therefore, when a
pharmaceutical company identifies a promising drug, speed to market becomes a major
consideration. Furthermore, Cook et al. observed that the size of clinical trials is one of
the large cost drivers during pharmaceutical development. Since pharmacogenomics is
based on targeting specific biomarkers, these types of clinical trials tend to require fewer
patients to demonstrate a statistically significant response, which according to Cook et
al., represents potential cost and time savings, while reducing the number of patients
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exposed to investigational products. Although the value of this type of innovation is
promising, the authors did not mention the need to demonstrate a clinically meaningful
response nor the changes required to adopt this innovation.
Other Approaches to Understanding Organizational Change
Researchers have used various frameworks and context to explain organizational
change. Lau and Woodman (1995) introduced change schema as a construct by which to
study organizational change. Lau and Woodman defined a schema as a hypothetical
cognitive structure that represents how individuals organize knowledge about a kind of
stimulus or a given concept. Lau and Woodman identified three general dimensions of
individual-level schema from the literature at the time: causality, valence, and inferences.
Causality is a frame of reference for connecting people and phenomena, a framework for
attributing causes of behavior to self and others. Valence refers to an individual’s
evaluation of the significance of an event or a relationship. Inferences enable individuals
to predict or infer what behaviors or events are likely to occur based on causality
frameworks. An individual’s schema is based on previous experiences and beliefs that
help forecast the possibility of events and behaviors. Lau and Woodman based their
change schema construct on individual-level schema to include a general attitude toward
change that consisted of locus of control, dogmatism, and organizational commitment.
The idea was that an individual’s change schema would prove an effective construct to
predict commitment to change. The researchers sampled 331 students concerning a major
potential change involving a university tradition of building a massive bonfire during a
prep rally before a state-rivalry football game. The researchers measured commitment to
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change with an 8-item scale designed to target the factors of an individual’s change
schema. Using cross-sectional structural equation modelling (SEM), Lau and Woodman
found that a student’s change schema did significantly and positively predict commitment
to change (b=.16). The study was important not only for introducing a construct by which
to study commitment to organizational change but for focusing on antecedents of change
commitment as well.
Researchers have studied employee response to change in the hospitality industry.
Hartline and Ferrell (1996) studied the management of customer-contact service
employees of a hotel that was implementing improvements to their customer service
program. The researchers developed and tested a model of service employee management
that involved three formal managerial control mechanisms: empowerment, behaviorbased employee actions, and management commitment to service quality. Hartline and
Ferrell sought to measure the impact the hotel managers’ commitment had on the effort
they displayed to ensure that customer-contact workers were implementing the planned
changes in hotel services. The researchers surveyed 797 hotel managers and customer
service workers in 279 hotel units via an adapted version of the Organizational
Commitment Questionnaire (OCQ) and found through cross-sectional SEM analysis that
managers who were committed to service quality were more likely to use behavior-based
evaluation and to empower their employees. Therefore, managers who were committed to
change were likely to use these leadership strategies to motivate their subordinates to
support organizational change. The study’s findings included important empirical
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information on organizational change and suggested ways to study the role of
management in employee commitment to change in service sectors.
Herscovitch and Meyer (2002) developed a multi-dimensional construct to study
commitment to change based on three dimensions: affective (positive feelings toward
commitment), normative (perceived obligation to comply), and continuance (perceived
consequences of failure to comply). Herscovitch and Meyer conducted three studies to
test their three-component model of workplace commitment to change. Study number one
consisted of 224 graduate psychology students to provide preliminary evidence for
construct validity; studies two and three involved hospital nurses (N = 157 and 108,
respectively) from various medical facilities. For these two studies, the researchers
hypothesized that employees experience three commitment-to-change mindsets (affective
commitment to change, normative commitment to change, and continuance commitment
to change) that could predict change-oriented behavior better than organizational
commitment could. Using hierarchical linear modelling across these two studies,
Herscovitch and Meyer found that when seen as a behavioral continuum of changesupport actions, commitment to change was a better predictor of behavioral support for
change than was organizational commitment. More specifically, affective commitment to
change positively predicted support in both samples, while normative commitment to
change positively predicted support in one sample and not the other. However,
continuance commitment to change did not predict change support in either sample.
Consequently, they did not find commitment to change a multi-dimensional construct.
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The study was important, however, for introducing compelling evidence that researchers
might effectively study commitment to change as a multi-dimensional construct.
In the law enforcement industry, researchers have also been active studying
change. Ford, Weissben, and Plamondon (2003) examined police officers’ attitudes and
receptivity to newly implemented changes in community policing procedures and the
impact of organizational commitment and strategy commitment on commitment to
change. The researchers hypothesized that managerial support, job experience, and
organizational commitment would positively influence community policing strategy
commitment. The researchers collected data from 432 police participants—363 officers
and 69 sergeants from 11 different police departments and used a modified OCQ as a
measurement tool. Using cross-sectional SEM analysis, Ford et al. found that managerial
support, job experience, and organizational commitment did positively predict
commitment to change, which in turn predicted community policing strategy
commitment. Consequently, the findings of the study suggested that work experience
factors, supervisory support, and organizational commitment could be important factors
of commitment to change strategies. In addition, the study was important for showing
that organizational and strategy commitment could be conceived as two distinct, albeit
related, levels of commitment.
What distinguished Fedor, Caldwell, and Herrold’s study (2006) was the
theoretical innovation of approaching organizational change as a multi-level
phenomenon. The researchers observed that previous studies on organizational change
measured the impact of change at the individual and organizational level, but did not
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consider that change may have different impacts and effects within and across various
organizational levels (e.g., upper, divisional, managerial, unit). Fedor et al. studied
individuals’ commitment to the change itself as well as their organizational commitment
in 34 different public and private organizations. Fedor et al. collected data from 806
managers and office workers via questionnaires. The researchers posited that both kinds
of commitment were best approached as a three-way interaction between an individual’s
favorableness to the change, the extent of change, and the impact of change on the
individual’s job. To study these variables at the group level, Fedor et al. split their sample
so that half of the participants who shared the same group-level effects would provide
group-level data. Fedor et al. used multi-level hierarchical linear modelling and computed
RWG scores (.90) to assess agreement among group members and ICC coefficients to
examine how much group membership accounted for individual member ratings to
ensure group membership reliability. They found that considering change at multiple
levels was necessary to gain a better understanding of individual employees’ reactions to
change and concluded that assessments of change at different organizational levels may
help to explain individual level responses to change.
Undesirable employee turnover is an inherit risk in organizational change.
Cunningham (2006) sought to expand research on organizational change that focused on
employee cognitions, attitudes, and behaviors by adding consideration of how employees
cope with change and their turnover intensions. Cunningham operationalized coping as
employee perception of how well they handled changing circumstances. Cunningham
used Herscovitch and Meyer’s (2002) multi-dimensional construct involving affective,

51
normative, and continuance dimensions to study employees’ commitment to change and
test his hypotheses that coping with change and turnover intentions were related to
commitment to change. Cunningham (2006) collected data via questionnaire from 299
employees of 10 National Collegiate Athletic Association (NCAA) programs undergoing
change initiated by incoming athletic directors. Using cross-sectional SEM, Cunningham
found that (a) the connection between turnover intentions and affective commitment to
change was mediated by coping with change, (b) the connection between turnover
intentions and continuance commitment to change was partially mediated by coping with
change, and (c) normative commitment to change directly affected turnover intentions.
Cunningham concluded that affective commitment may increase when employees
participate in the change process, as involvement helps them cope with change. However,
the alpha coefficient for the coping with change measure was .63, suggesting that this
mediating construct was below the customarily acceptable level of reliability.
Others have used psychological concepts to explain employee reaction to change.
Chen and Wang (2007) attempted to assess psychological reactions to change using the
concept of locus of control in relation to Herscovitch and Meyer’s (2002) ideas of an
individual’s affective, normative, and continuance commitments to change. Locus of
control refers to a person’s perception of their ability to exercise control over contextual
elements of a situation, and individuals are referred to as being either internals or
externals. Those who consider themselves internal believe they have control over their
situations (i.e., that the locus of control is within them), and those who consider
themselves external believe that situational factors control their lives (i.e., that the locus

52
of control resides outside of them). Chen and Wang (2007) surveyed 256 customs
workers in a service department at a border city in Southern China. The organization was
implementing a new employee performance review system. Chen and Wang employed
Herscovitch and Meyer’s (2002) 18-item scale as a measurement tool, and using crosssectional hierarchical regression analysis, found that locus of control was positively
related to affective and normative commitment to change (r = -.22, p < .01; r = -.19, <
.01, respectively) and negatively related to continuance commitment to change (r = .24, p
< .01). In addition, those with high internal locus of control showed higher affective and
normative commitment to change than those with high external locus of control did, but
those with high external locus of control were higher in continuance commitment to
change. Chen and Wang (2007) concluded that internals would commit to change out of
personal desire (affective) or obligation (normative), while externals would commit to
change because of their perception of the costs associated with failure to support change
(continuance). The study was important for four reasons: (a) it showed that locus of
control could predict employees’ commitment to a specific change, (b) it increased
understanding of the psychological mechanisms through which people with different loci
of control react to change, (c) the results provided support for Herscovitch and Meyer’s
model of workplace commitment, and (d) the study extended the three-component model
of change commitment to a non-Western context.
Gap in the Literature
All these critical studies in the change management literature serve to highlight
important research done to understand employee engagement with organizational change.
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Yet, the settings for these studies were not the pharmaceutical industry. Goksoy et al.
(2012), Hartline and Ferrell (1996), Oreg and Sverdlik (2011), Seo et al. (2012),
Stensaker and Meyer (2008), and Tyler and De Cremer (2005) specifically studied
employee response to change in other industries, including nursing, law enforcement,
college, sports, and business, leaving a gap in scholarly research on employee response to
change in the pharmaceutical industry.
There is a need to narrow this gap, as pharmaceutical research and development is
the cornerstone of one of the most expensive and high-risk industries and crucial for
addressing the world’s unmet medical needs. Golec et al. (2010) estimated the cost of
bringing a drug from discovery to market at $1.8 billion, while Cook et al. (2009) noted
that only 1 in 10,000 discovered compounds make it to market. In addition, this industry
frequently engages in M&As, a type of large-scale organizational change. Since 50-80%
of M&As fail according to Budwar et al. (2009), it is even more important to study this
phenomenon in such an important and high-risk industry. Budwar et al. cited lack of clear
communication and a lack of employee involvement in the change among the reasons
M&As fail. These are among the variables I will examine in this study of employee
response to large-scale change in the pharmaceutical industry.
Summary and Conclusions
Based on this synthesis of the literature, it appears that inclusion of employees in
organizational change implementation increases their support of change (Barratt-Pugh et
al., 2013; Budhwar et al., 2009; Franckeiss, 2012; Goksoy et al., 2012; Marks & Mirvis,
2011; Shibayama et al., 2011; Whelan-Berry & Sommerville, 2010). Viewing employees
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as stakeholders concerned with an organization’s overall success may help establish a
bottoms-up approach to including employees in the change process (Duckworth, 2014;
Greenwood & Buren III, 2010). In addition, researchers found that employees can have a
nuanced reaction to change, that they do not always outright support or resist change
(Mishra & Bhatnagar, 2010; Oreg & Sverdlik, 2011). Employees can both resist and
support aspects of the same change, and their personal attitudes toward change interacts
with their attitudes toward the change agent, which can result in ambivalence (Mishra &
Bhatnagar, 2010; Oreg & Sverdlik, 2011). Such findings encourage researchers to more
accurately measure employees’ response to change (Oreg & Sverdlik, 2011).
Additionally, effective change management also includes clear communication of change
before and during implementation, as well as employee and organizational change
histories as other key factors in successful organizational change (Budhwar et al., 2009;
Goksoy et al., 2012; Whelan-Berry & Sommerville, 2010). As Barratt-Pugh et al. (2013),
Budhwar et al. (2009), and Marks and Mirvis (2011) demonstrated, the role human
resources departments and change managers play in successful change and how they can
facilitate the blending of organizational cultures is key. In addition, transformational
leadership, an inclusive leadership style that includes the concerns and views of
subordinates, has proven effective in organizational change because it can include
employees in the planning and implementation of change (Charbonnier-Voirin, El
Akremi, & Vandenberghe, 2010; Ricke-Kiely & Robey-Williams, 2011; Wang & Rode,
2010). Although these studies focused on organizational change and some specifically on
employee response to change, the settings were not in the pharmaceutical industry.
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The major shortcoming is that research on employee support of change in the
pharmaceutical industry is virtually nonexistent. Given the high stakes nature of the
pharmaceutical industry (Golec et al., 2010) and the pervasiveness of change in the
industry (Bordia et al., 2011), such work is clearly needed. In my study, I sought to
contribute to needed research on employee response to change in the pharmaceutical
industry. Because employee response to change in other areas of study involves
behavioral and attitudinal components (Jaros, 2010), as well as emotional ones (Mishra &
Bhatnagar, 2010), including feelings of ambivalence (Oreg & Sverdlik, 2011), I
approached employee involvement in change in the pharmaceutical industry as a
multidimensional construct, similar to Herscovitch and Meyer’s (2002) approach.
Compliance, cooperation, and championing should encompass the range of employee
support from minimal support of change to enthusiastic promotion of change, with active
and passive resistance completing the full spectrum of employee reaction to change. With
this study, I offer a starting point for future research on employee response to large-scale
organizational change in the pharmaceutical industry.
In Chapter 3, I provide a detailed description of the methodology I used. This
chapter includes the selection of research participants, the quantitative, correlational
research design and rationale, population and sampling procedures using
SurveyMonkey’s participant pool, as well as data collection and analysis. It also includes
a discussion of threats to validity.
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Chapter 3: Research Method
The purpose of this study was to reduce the knowledge gap in scholarly research
on large-scale organizational change in the pharmaceutical industry by evaluating key
predictors of employee response to large-scale change. These key predictor variables
were ICR, ICD, PCS, and CHC. Using a synthesis of transformational leadership,
stakeholder theory, and change management theory as the framework, I statistically
examined which of these variables predicts RC (continuum ranging from active resistance
to championing) and SC (CM, CP, and CH). RC and SC were the two primary dependent
variables. CM, CP, and CH (subscales of SC) were also dependent variables. By
providing information on employee response to change, this study has practical
implications for pharmaceutical managers and change leaders planning and implementing
change.
In this chapter, I outline the methods enacted in the study, as well as the specific
procedures to test the hypotheses associated with the two primary research questions and
three additional research questions related to the subscale of SC. This chapter also
includes acknowledgement of the limitations of the design, and potential issues of
validity to the study, while giving special regard to methods used to remedy these issues.
Research Design and Rationale
I used a quantitative, correlational design in this study. This was the most
appropriate method because the aim of the research was to examine statistically the
effects of quantifiable concepts (Howell, 2012). The focus of this research was to
investigate the effects of ICR, PCS, ICD, and CHC on RC, SC, and the subscales of SC.
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Each of these variables was measureable through numerical responses to a survey
instrument. I therefore utilized a research design that allowed for an objective view of the
variables of interest, and which permitted a relatively higher level of certainty while
forfeiting the richness of detail associated with qualitative research (Bansal & Corley,
2011).
Qualitative research has no standard measures, and instead relies on the
researcher’s interpretations (Bansal & Corley, 2011). This would have been an
appropriate research method if, for example, I was interested in an in-depth exploration
of the participants' emotional responses to M&As in the pharmaceutical industry. Thus, I
rejected the qualitative methodology. By contrast, the mixed methods approach requires a
comprehensive data collection process (Crosbie & Ottmann, 2013; Heyvaert, Maes, &
Onghena, 2013). This would have required a pilot study followed by the main study, and
would have involved both quantitative and qualitative methods. Since my focus was on
determining key predictors, without the need for rich, qualitative details, the quantitative
method fully satisfied the objectives of my research. Therefore, I rejected the mixed
method approach as well and utilized a quantitative design.
Methodology
My research study followed a correlational approach, which was appropriate
because the scope of the research was to determine the effect of one or more measureable
variables on a measureable outcome variable, in alignment with the guidelines provided
by Creswell (2005). With correlational research, the researcher’s aim is to determine
links among several variables. In my study, I used these links to provide a predictive
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formula to express a potential relationship where ICR, ICD, PCS, and CHC, affect RC,
SC, and the subscales of SC (Mitchell & Jolley, 2001). This approach resulted in five
regression analyses aligned with the two research hypotheses. The first analysis,
conducted to test Hypothesis 1, was to predict the continuum of RC, which includes both
positive and negative reactions, ranging from active resistance to championing change.
The remaining analyses, conducted to test Hypothesis 2, were to predict SC,
operationalized through CM, CP, and CH. Measures for ICR, ICD, PCS, and CHC were
the independent, or predictor variables.
Population
The population examined in this research was comprised of pharmaceutical
industry employees with various years of experience. These individuals worked at
traditional pharmaceutical companies that discover and develop investigational medicinal
products (IMPs). The participants also worked at biotechnology companies that discover
IMPs, but outsource development to contract research organizations (CROs), which were
also a population of interest. In order to be eligible, the participants must have also
experienced some large-scale change in their company, such as an M&A, to be included
in the study sample. This change had to have occurred at their current employer or at a
previous organization where the participant worked.
Biotechnology companies, smaller CROs, and small pharmaceutical companies
have a few to several hundred employees. However, larger CROs can have more than
10,000 employees, while larger pharmaceutical companies can have up to 100,000
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employees (Masri, Ramirez, Popescu, & Reggie, 2012). I targeted these and other types
of pharmaceutical industry employees for my study.
Sampling and Sampling Procedures
To gather sample participants from this population, I contacted pharmaceutical
industry employees who recently experienced a large-scale change using
SurveyMonkey’s sample selection service. A collector at SurveyMonkey contacted
employees from qualifying companies who had already provided consent to be contacted
for surveying, and requested their participation in the study. I instructed SurveyMonkey
to collect participants based on the following criteria:


Participants must have been either employees at pharmaceutical companies,
including CROs and biotechnology companies, or organizational change experts
within the pharmaceutical industry.



Participants must have had experience with the pharmaceutical industry, though
varying amounts of experience are acceptable.



Participants must have experienced some large-scale change in their company. I
provided participants with an informed consent statement on the front page of the
survey, requiring consent to participate in the study before continuing.
The sampling method used was stratified sampling, because I gathered a

purposive, targeted sample representing a diverse mix of industry experience and
inclusion of at least one change expert, as recommended by Howell (2012). This
approach led to a sample of participants who had previous experience with large-scale
change and a sample that was approximately proportionally representative of the
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employee mix at a pharmaceutical company. Through SurveyMonkey’s participant pool,
I ensured targeting of a diverse sample representing various levels of experience and job
categories, including change management experts.
For my study, I used multiple linear regression as the statistical analysis
technique. Using G*Power version 3.1.9 (Faul, Erdfelder, Buchner, & Lang, 2013), I
calculated the necessary sample size to achieve empirical validity. For a regression
analysis with a generally accepted power of 0.80 (Cohen, 1992), an alpha of 0.05, and
four predictor variables, the multiple linear regression requires a minimum of 85
participants to detect a medium effect, or f2 = 0.15 (Cohen, 1977; Herscovitch & Meyer,
2002). I chose a medium effect size as the expected result of a generic statistical finding,
which is typical when the specific effect size is not well known, according to Faul,
Erdfelder, Buchner, and Lang (2012). At the time of the survey, the possibility of a
regression analysis with four predictor variables existed. Thus, to assess a relationship
with 95% certainty that it did not occur by chance, I sought to assemble a sample of at
least 85 participants. With only three predictor variables in any one of the linear
regression analyses performed, the minimum sample size would be 77. Thus, the
sampling was performed with a conservative approach and any valid samples greater than
77 would have the effect of simply increasing power and confidence in the hypothesis
tests.
To achieve a final sample of at least 85 participants, I sent 170 surveys to
prospective participants. This sampling frame allowed for a 50% return rate while still
meeting the minimum computed sample size, as previous research indicated that this is an
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average response rate for academic studies (Baruch, 1999). If the main sample had not
met the minimum size of 85 participants, I would have disseminated additional surveys,
which I did and ended up with 98 completed surveys.
Procedures for Recruitment and Informed Consent
I used an informed consent document as the discussion framework for obtaining
consent from study participants (see Appendix B). In establishing the relationship with
the study participants, I introduced the study to the participant by explaining the purpose
of the study, describing the procedures, disclosing the risks and benefits, establishing the
role of the participant, and estimating the time involved. I informed all participants that
participation was voluntary. I also informed participants that I would not use any
identifiable data in the study and that they could drop out of the study at any time without
penalty.
Participants in this study received a copy of the informed consent document at the
front of the survey. This document included the contact information for me, my
dissertation advisor, and Walden’s IRB (approval number 07-02-15-0136499 with an
expiration date of July 1, 2016; see Appendix C). I did not allow prospective participants
to take part in the study without first indicating that they consented to be participants in
the study. Only those who selected that they read the informed consent document and
agreed to participate were allowed to continue to the survey questions. Thus, agreement
to continue and completion of the survey constituted voluntary participation.
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Data Collection
For participants who agreed to participate in the study and provided informed
consent, SurveyMonkey provided a link to the survey. Through the online survey, I
administered the BSCS (Herscovitch & Meyer, 2002) supplemented with industryspecific questions, as well as a few questions to better understand the characteristics of
the population. I labeled participants using a confidential identifier so that their data may
be identified if they later choose to opt out of the study. I stored data on the survey host
server until it was time to download and store it on a thumb drive for access and analysis.
I did not follow up with participants in any way.
Operationalization of Constructs
The four independent variables in this quantitative, correlational study were ICR,
PCS, ICD, and CHC (including considerations of the quality and frequency of
communication). RC and SC were the two primary dependent variables. RC was
represented on a continuum ranging from a negative reaction of active resistance to a
positive reaction of championing change. SC was a composite index computed by
combining the dependent variables representing the subscales of CM, CP, and CH. The
following section is a discussion of how I operationalized these variables.
Dependent Variables
Reaction to change (RC). The way in which an employee reacts to large-scale
organizational change fell on a continuum ranging from a negative reaction of active
resistance to a positive reaction of championing change, represented by a 9-point Likert
scale. Each participant selected one of nine responses from the BSCS instrument that lie
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on the continuum on Question 10 of the survey, as represented in Figure 1. The
continuum of possible responses on the reaction to change continuum. I converted this
continuum to an index ranging from 0-100, for the sake of consistency among the
dependent variables, as follows:
RC = 12.5 (L) – 12.5 where L = the raw Likert scale response.
Thus, I converted a response of 1 to 0, and a response of 9 to 100.

Figure 1. The continuum of possible responses on the reaction to change continuum.
Support of change (SC). The manner in which an employee supports large-scale
organizational change involves three levels of support: compliance (CM, 3 survey
questions), cooperation (CP, 8 survey questions), and championing (CH, 6 survey
questions). Much like RC, these represent a spectrum of increasing support of a change
initiative. Participants answered the items associated with each category on a 7-point
Likert-type scale from the BSCS instrument. I calculated subscales of support as the
mean of responses to the corresponding survey questions, and each of these subscales
represented a dependent variable for one test of Hypothesis 2, with the intention of
capturing detail on each specific facet of support. The instrument’s developers,
Herscovitch and Meyer (2002), support this scoring scheme, where the specific subscales
should be measured. Herscovitch and Meyer also indicated that the overall score, taken as
the average of all three subscales, is representative of the degree to which a respondent
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supported the change overall. Higher scores indicate a greater degree of support of
change. A composite index for SC was also a dependent variable, with higher values
indicating greater support of change. SC was simply the average of the converted values
for the three subscales, CM, CP, and CH, as follows:
SC = (CM + CP + CH) ÷ 3.
Compliance (CM). This construct of support measured the extent to which
employees accepted a change. This involves how much employees agree to accept role
changes and adjust their workplace habits to comply with those changes. I measured this
variable as the mean of Survey Questions 11–13 on the measures of behavioral support
for change portion of the survey, where higher scores corresponded to greater compliance
with change. I converted the mean response to a subscale for compliance (CM) that
ranged from 41 to 60, as follows:
CM = 3.167 (LCM) + 37.833 where LCM = the mean Likert response for
compliance.
Cooperation (CP). This construct of support measured the extent to which
employees assisted in changing the company. This construct defined how well employees
engaged in change-related behaviors, avoided former practices, and tolerated temporary
disruptions caused by the change. I measured this variable as the mean of Survey
Questions 14–21 on the measures of behavioral support for change portion of the survey,
where higher scores corresponded to greater cooperation with change. I converted the
mean response to a subscale for cooperation (CP) that ranges from 61 to 80, as follows:
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CP = 3.167 (LCP) + 57.833 where LCP = the mean Likert response for
cooperation.
Championing (CH). This construct of support measured the extent to which
employees encouraged others to cooperate with and accept the change. This construct
gauged how actively employees spoke positively about the change, overcame resistance
to the change, and persevered with the change in order to reach goals. I measured this
variable as the mean of Survey Questions 22–27 on the measures of behavioral support
for change portion of the survey, where higher scores corresponded to greater
championing of the change. I converted the mean response to a subscale for championing
(CH) that ranged from 81 to 100, as follows:
CH = 3.167 (LCH) + 77.833 where LCH = the mean Likert response for
championing.
Independent Variables
The independent variables of the study measured the participants’ perceptions of
the change’s implementation. These perceptions included initial change reaction,
involvement in change design, perceived change success, and change communication. I
measured these through responses to the pharmaceutical industry questions portion of the
survey.
Since I developed this portion of the survey, I ran it through a brief field test. For
this, I targeted three respondents to assess the survey for face validity, and to determine if
the survey was clear and the responses comprehensive and logical. I asked these
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respondents to provide feedback on any areas of the assessment they felt needed
improvement, with the intent to make changes as appropriate.
Initial change reaction (ICR). This item asked participants to rank their response
to first learning about the organizational change as either positive or negative. The range
of initial reactions ran from “I am going to lose my job” = 1 to “I may get promoted” = 7.
Thus, lower scores on this variable corresponded with a negative opinion of the change,
while higher scores corresponded with a positive opinion of the change. I used a single
survey question to assess this independent variable.
Involvement in change design (ICD). Involvement in change design refers to the
degree to which an employee takes part in the planning and implementation of change.
The range of involvement ran from “not involved” = 1 to “very involved” = 7.
Employees may be heavily involved in change design to the degree that they willingly
cooperate, or even champion the proposed change. Alternatively, employees may be
minimally involved or not involved at all. As such, a higher degree of involvement
corresponded with higher scores.
Perceived change success (PCS). Perceived change success refers to the degree
to which employees perceived the proposed change to be completely and effectively
implemented. Employees chose on a scale from “a complete failure” = 1 to “a resounding
success” = 7. As such, higher scores indicated perceptions of an increased amount of
success.
Change communication (CHC). Change communication refers to the manner in
which management conveys information relevant to the proposed change to employees,
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as well as the frequency. Change communication involves the clarity and quality of
communication, where “Very bad” = 1, and “Very good” = 7. Frequency described how
often the change was communicated to employees, and ranged from “Rarely” = 1, to
“Very often” = 7. I calculated the change communication score as the average of these
two measures. Thus, this variable ranged from 1 to 7, where higher scores corresponded
with a frequent, high quality level of communication about the change.
Data Analysis
I entered data into SPSS version 22.0 for Windows and used descriptive statistics
to better understand the sample characteristics and the research variables used in the
analysis. I calculated frequencies and percentages for any nominal (i.e., categorical)
variables of interest, such as job function and highest level of education completed. For
any continuous data (i.e., scale or ratio), I calculated means and standard deviations.
I screened the data for accuracy, missing data, and outliers. I calculated
descriptive statistics and frequency distributions to determine that responses were within
a possible range of values, and that outliers did not distort data. I tested for the presence
of outliers by calculating standardized values. Standardized values represent the number
of standard deviations an individual score falls from the mean of those scores. According
to Tabachnick and Fidell (2012), participants with scores more than 3.29 standard
deviations from the mean are considered outliers, and as a result, that participant’s survey
should be removed from the data set. Additionally, I examined cases with missing data
for non-random patterns and excluded participants with large portions of non-random
missing data from the sample.
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After screening the data, I conducted the necessary analyses to test the hypotheses
and to inform the research questions of interest, restated here for reference. I conducted
one regression analysis to address Research Question and Hypothesis 1 and four
regression analyses for Research Question and Hypothesis 2.
Multiple regression is an appropriate analysis when the goal is to assess the extent
of a relationship among a set of dichotomous or interval and ratio predictor variables on
an interval and ratio criterion variable. I used the following regression equation (main
effects model):
𝑌̂ = β0 + β1X1 + β2X2 + … + βkXk
where 𝑌̂ = the predicted value for the response variable, β0 = constant, β1 = first
regression coefficient, β2 = second regression coefficient, βk = kth regression coefficient,
and Xi = predictor variables (Tabachnick & Fidell, 2012). I did not assess any interaction
terms because my goal was not to determine moderating effects of any of the research
variables.
1. What is the relationship between RC and the predictor variables ICR, ICD, PCS,
and CHC?
H01: No relationship exists between RC and the predictor variables ICR,
ICD, PCS, and CHC.

1 = 2 =  = k = 0.
Ha1: A relationship exists between RC and the predictor variables ICR,
ICD, PCS, and CHC.
At least one j ≠ 0.
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2. What is the relationship between SC and the predictor variables ICR, ICD, PCS,
and CHC?
H02: No relationship exists between SC and the predictor variables ICR,
ICD, PCS, and CHC.

1 = 2 =  = k = 0
Ha2: A relationship exists between SC and the predictor variables ICR,
ICD, PCS, and CHC.
At least one j ≠ 0
Multiple Linear Regression
To examine the two research questions, test the hypotheses, and assess how well
the four perceptions of a change predict employee response to change, I conducted two
sets of multiple linear regressions. The first multiple linear regression tested Hypothesis
1, assessing the collective effect of the four independent variables (ICR, ICD, PCS, and
CHC) on RC (Stevens, 2009).
The next set of three multiple linear regressions tested Hypothesis 2, assessing the
collective effect of the four independent variables (ICR, ICD, PCS, and CHC) on each of
the three sub-construct dependent variables individually (CM, CP, and CH) that comprise
SC (the second of the two primary dependent variables). Following these three regression
analyses for the support of change, I conducted a fifth and final overall regression. In this
final regression analysis, I used the same four independent variables, but calculated the
results using a single dependent variable (SC). This single dependent variable was the
mean of the three SC sub-scales.
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I used the F test to assess whether the set of independent variables collectively
predicted the dependent variable. I reported R2, the multiple correlation coefficient of
determination, and used it to determine how much variance in each dependent variable
the set of independent variables can account for. I used t-tests within the regression
model to determine the significance of each predictor and used beta coefficients to
determine the extent of prediction for each independent variable, while controlling for the
other included predictors. Regarding significant predictors in the final regression model,
for every one unit increase in the predictor, the dependent variable was predicted to
increase or decrease by the unstandardized beta coefficient.
Prior to analysis, I assessed the assumptions of multiple linear regression. The
assumptions of multiple linear regression include linearity, homoscedasticity, and
absence of multicollinearity. Normality assumes that error term in the model is normally
distributed, while homoscedasticity assumes that error terms have equal variance. I
assessed normality and homoscedasticity by examination of scatter plots, used a normal
probability plot to assess normality, and a residual scatterplot to assess homoscedasticity
(Tabachnick & Fidell, 2012). The absence of multicollinearity assumes that predictor
variables are not too closely related, and I assessed this assumption using Variance
Inflation Factors (VIF). VIF values over 10 suggest the presence of multicollinearity and
a violation of the assumption (Stevens, 2009).
Threats to Validity
Causal inference is usually a potential issue regarding internal validity. However,
my goal in this study was not to demonstrate cause and effect; it was to show correlation.
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Causal inference is only applicable when the cause precedes the effect (Tabachnick &
Fidell, 2012). In this study, it was difficult to determine that the predictor variables were
the de facto cause of response to change. In some cases, participants may have been
supportive of the cause, and inadvertently responded in a more positive manner regarding
the communication and success. In addition, involvement with the change may have been
linked with support or a positive reaction because of confounding factors such as
personal pride. I noted these as limitations, and Creswell (2005) recommended exercising
caution while interpreting results where this issue may be present.
External validity refers to the ability of the general population to extrapolate a
study’s findings. The results of my study may not be generalizable to a population of
employees in organizations outside of the pharmaceutical scope. Such organizations were
not my focus, and are thus irrelevant to the findings. In addition, the allowance of
participants to take the survey assessments online presented the concern of situational
validity. Participants may have been in an uncomfortable area, or under conditions that
may have altered their responses. This was compounded by the cross-sectional nature of
the study, wherein a single opinion was gathered at one point in time. Potential issues
arise if a participant was in an extreme mood, or was suffering from any maladies, which
may detriment the accuracy of the responses (Mitchell & Jolley, 2001). However, I
encouraged participants to take their time, and provide broad, honest responses.
Ethical Procedures
A researcher who conducts studies involving human subjects has a responsibility
to inform and protect participants (Bloomberg & Volpe, 2012). In conducting this
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research study, I adhered to the ethical and moral guidelines prescribed by federal
regulations and Walden University’s Institution Review Board (IRB). I interacted with
human subjects during this study. My data collection approach entailed the use of a single
compiled survey instrument, administered at only one point in time. The compiled survey
included two sets of questions. These included the pharmaceutical industry questions and
the measures of behavioral support for change questions. Additionally, I used notification
memoranda to invite participation. The following section entails the approach to
informed consent and a brief discussion on data storage, retention, and destruction to
protect confidentiality.
The survey instrument for this study was designed to minimize the need to collect
identifiable data. In accord with IRB and federal guidelines, I safeguarded all data and
information to protect confidentiality. The safeguard measure for data storage was a
locked file in my residence where I will retain the data securely for a period of 5 years
after the research was completed. Upon expiration of the 5-year retention period, I will
permanently destroy all research-related data and information pertaining to this study.
Summary
In this chapter, I outlined the quantitative design, as well as rationale for the use
of this research method. I also described the stratified sampling method used to gather
participants from the population of pharmaceutical industry professionals who had
experienced at least one large-scale organizational change. Additionally, I
operationalized the variables of interest, and included the instrumentation and procedures
for data collection. I explained the treatment of such data and statistical procedures used
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in addressing the hypotheses, and included a rationale for the analyses and the
presentation of results. Finally, I addressed limitations and ethical concerns, with special
consideration of methods that may remedy these potential difficulties or harms. I adhered
strictly to these procedures in gathering and analyzing data to cleanly and efficiently
address the research problem at hand.
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Chapter 4: Results
The purpose of this quantitative, correlational study was to narrow the knowledge
gap on large-scale organizational change in the pharmaceutical industry. Researchers
have sought to understand employee engagement and response during large-scale change
initiatives in nonpharmaceutical industries (Goksoy et al., 2012; Herscovitch & Meyer,
2002; Lau & Woodman, 1995; Oreg & Sverdlik, 2011). However, employee responses to
change in the pharmaceutical industry remain understudied and underrepresented. In the
study, I tested four factors that I hypothesized affect the change’s implementation: ICR,
ICD, PCS, and CHC; these factors functioned as independent/predictor variables in this
study. The dependent variables were RC, which included the full spectrum of reactions
ranging from active resistance to championing change and operationalized measures of
SC (CM, CP, and CH). One additional dependent variable, SC, represented a composite
index of support of change, and was calculated as the mean of the three subscales (CM,
CP, and CH).
This chapter describes the pre-analysis data screening that I performed prior to
conducting the multiple regression analyses to explore the two research questions. In it, I
review demographic information and descriptive statistics prior to presenting the detailed
analyses ordered by research question. For each analysis, I assess the assumptions of
normality, homoscedasticity, and absence of multicollinearity before accepting or
rejecting the appropriate hypotheses based on the results. I also include a summary of the
results and of the full chapter.
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Field Test and Pre-Analysis Data Screening
I used the first 11 completed responses as a field test to assess the quality of the
responses and to determine whether the right participants were responding to the survey.
A few respondents listed job roles, such as cashier, that did not appear consistent with
those in the pharmaceutical industry. Three respondents selected other and wrote not
applicable as their pharmaceutical industry job category. Based on these initial responses,
I decided to add a screening question that specifically asked participants if they work in
the pharmaceutical industry. Those who answered no were disqualified, and those who
answered yes were allowed to complete the survey. These first 11 completed surveys
were therefore not included in the final analysis, as it was hard to determine with
certainty that the respondents worked in the pharmaceutical industry.
Data Collection and Sample Characteristics
I collected data over a 2-week time frame in July 2015. A total of 914 people
attempted to access the online survey. Of these, 816 either did not fit the inclusion criteria
or did not consent to the survey and were removed from the dataset. I then assessed the
data for nonrandom missing cases and did not find any. I further checked for univariate
outliers by examination of standardized values, which indicate the distance a participant’s
score falls from the mean, and is measured in standard deviations. I considered any cases
3.29 standard deviations away from the mean as outliers to be removed (Tabachnick &
Fidell, 2012). As I did not find any outliers in the data, the final dataset contained a total
of 98 participants.
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Of the 98 participants in the final data set, 45% were male (n = 44) and 55% were
female (n = 54). Many were between 30 and 44 years of age (42, 43%) and reported
household earnings between $50,000 and $74,999 per year (15, 15%). The largest
proportion of participants came from the mid-Atlantic region of the United States (20,
20%). Of the pharmaceutical industry job category options, the largest group of
participants was researchers (18, 18%). Many of the participants’ highest level of
education was a Bachelor’s degree (38, 39%). A large portion of the participants’
companies underwent a merger or acquisition as a large-scale organizational change (35,
36%). This mix of participants approximately represents the employee mix at a typical
pharmaceutical company. The frequencies and percentages of demographic information
are presented in Table 1.
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Table 1
Frequencies and Percentages of Demographics
Demographic

n

%

What is your gender?
Male
44
45
Female
54
55
What is your age range?
18 – 29 years
12
12
30 – 44 years
42
43
45 – 59 years
32
33
60 + years
12
12
How much total combined money did all members of your household earn last year?
$10,000 to $24,999
2
2
$25,000 to $49,999
14
14
$50,000 to $74,999
15
15
$75,000 to $99,999
13
13
$100,000 to $124,999
8
8
$125,000 to $149,999
11
11
$150,000 to $174,999
4
4
$175,000 to $199,999
1
1
$200,000 and up
14
14
Prefer not to answer
16
16
United States Region
New England
16
16
Middle Atlantic
20
20
East North Central
15
15
West North Central
7
7
South Atlantic
12
12
East South Central
4
4
West South Central
3
3
Mountain
9
9
Pacific
10
10
Prefer not to answer
2
2
Select the pharmaceutical industry category that best describes your job role?
Executive (e.g., Vice President)
7
7
Management (e.g., Manager, Director)
17
17
Professional (e.g. Project management, Marketing)
10
10
Support (e.g., Information technology)
12
12
Research (e.g., Scientist)
18
18
Change Management Professional (e.g., Six Sigma Expert)
1
1
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Other
What is the highest level of education you have completed?
High school or equivalent
Bachelor’s Degree
Master’s Degree
Doctorate or other advanced degree (e.g., PhD, MD, PharmD)
What best describes the large-scale organizational change you
experienced?
Merger or acquisition
Major process redesign
Restructuring
Downsizing
Upsizing
Other large-scale change

33

34

24
38
17
19

25
39
17
19

35
17
22
12
7
5

36
17
22
12
7
5

Note. Due to rounding errors, not all percentages may sum to 100.
Participants in the sample demonstrated a wide range of years spent in the
pharmaceutical industry, where the minimum was one year and the maximum amount of
time spent was 56 years. Visual examination of the variables germane to the study
revealed that the lowest scores tended to be found in the ICD variable, where none
responded with higher than a value of three out of seven. This is reflected in the mean
value, which was also found to be much lower than any other independent variable. The
spread and central tendency of the continuous variables are presented in Table 2.
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Table 2
Descriptive Statistics of Continuous Variables
Composite Scores
Years in the Pharmaceutical Industry
ICR
CHC
ICD
PCS
RC
SC

Min. Max.
1
1
1
1
1
0
61

56
7
7
3
7
100
80

M

SD

14.39 12.37
3.49 1.39
3.44 1.81
1.45 0.66
3.96 1.65
58.29 20.77
70.94 3.64

Reliability
I conducted Cronbach's alpha tests of reliability and internal consistency on
scales, with one test per scale. The Cronbach's alpha provides mean correlation between
each pair of items and the number of items in a scale (Brace, Kemp, & Snelgar, 2006). I
interpreted the alpha values using George and Mallery’s (2010) guidelines where α > .9 is
excellent, >.8 is good, >.7 is acceptable, >.6 is questionable, >.5 is poor, and < .5 is
unacceptable. Results for SC indicated excellent reliability (α = .93). Reliability statistics
for the composite score are presented in Table 3.
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Table 3
Cronbach’s Alpha Reliability Statistics for the Composite Score
Scale # of Items
SC

17

α
.93

Detailed Analysis
Research Question 1: Reaction to Change (RC)
1. What is the relationship between RC and the predictor variables ICR, ICD, PCS,
and CHC?
H01: No relationship exists between RC and the predictor variables ICR,
ICD, PCS, and CHC.

1 = 2 =  = k = 0.
Ha1: A relationship exists between RC and the predictor variables ICR,
ICD, PCS, and CHC.
At least one j ≠ 0.
To assess the first research question, I used a multiple linear regression to assess
if the four independent variables (ICR, ICD, PCS, and CHC) predict RC. Prior to
conducting the analysis, I assessed the assumptions of normality, homoscedasticity, and
absence of multicollinearity. To check that the data fit a normal distribution, I checked
the normal P-P plot to ensure that the data followed the normal line. As there were no
large deviations from the normal line, the assumption was met (see Figure 2). To assess
the assumption of homoscedasticity, or equal variance in the error terms, I used a
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scatterplot of standardized residuals as a function of standardized predicted values. As the
data points are rectangularly and randomly distributed around zero, the assumption was
met (see Figure 3). I used VIFs to assess the assumption of absence of multicollinearity.
Values for VIFs less than 10 indicate that there is not extreme multicollinearity (Stevens,
2009). As the largest VIF in the model was 2.14, the assumption was met.

Figure 2. Normal P-P plot to check whether data used to assess the relationship between
the predictor variables and RC are normally distributed.
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Figure 3. Scatterplot of standardized residuals as a function of standardized predicted
values for RC.
As the assumptions were met, I proceeded with the regression analysis to
determine whether ICR, ICD, PCS, and CHC significantly predict RC. The results of the
analysis indicated that the model is statistically significant, F(4,93) = 5.50, p = .001, R2 =
0.19 (see Table 4). The results of the multiple linear regression indicated that the null
hypothesis was rejected in favor of the alternative, which states that a significant
relationship exists between the four predictor variables and RC.
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Table 4
ANOVA Results for Regression One
Source
Regression
Residual
Total

SS

df

MS

F

p

8005.765
33851.697
41857.462

4
93
97

2001.441
363.997

5.499

.001

The R2 indicates that the model predicts 19% of the variability in the dependent
variable. Although the model is significant, there were no significant individual
predictors, as depicted by the t-statistics and p-values in Table 5. This is potentially due
to issues of multicollinearity or shared significance among predictors, where the model
would be unable to determine specifically where significance lies (Stevens, 2009). ICR
approached significance, but ultimately was found to be insignificant at an alpha of .05 (B
= 3.37, t = 1.92, p = .057). Because the regression equation was significant, the following
equation may be used to predict RC:
𝑅𝐶 = 3.37(𝐼𝐶𝑅) + 1.11(𝐶𝐻𝐶) − 0.49(𝐼𝐶𝐷) + 2.57(𝑃𝐶𝑆) + 33.26
The results are presented in Table 5.
Table 5
Results for Multiple Linear Regression to Predict RC
Source

B

SE

Constant
33.26
6.29
ICR
3.37
1.75
CHC
1.11
1.53
ICD
-0.49
3.23
PCS
2.57
1.72
Note. F(4,93) = 5.50, p = .001, R2 = 0.19

β

T(98)

Critical t

p

0.23
0.10
-0.02
0.20

5.29
1.92
0.73
-0.15
1.49

1.98
1.98
1.98
1.98
1.98

.001
.057
.468
.880
.139
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Research Question 2: Support of Change (SC)
2. What is the relationship between SC and the predictor variables ICR, ICD, PCS,
and CHC?
H02: No relationship exists between SC and the predictor variables ICR,
ICD, PCS, and CHC.

1 = 2 =  = k = 0
Ha2: A relationship exists between SC and the predictor variables ICR,
ICD, PCS, and CHC.
At least one j ≠ 0
I utilized four multiple linear regressions to assess Research Question 2. The first
was to determine whether the four independent variables (ICR, ICD, PCS, and CHC)
predict SC. I then examined the three individual regression equations where the
dependent variables were the SC subscales of CM, CP, and CH. I checked assumptions of
normality, homoscedasticity, and absence of multicollinearity before conducting the
analysis. Normality assumes that the data follows a normal, bell-shaped distribution. I
used a normal P-P plot to check the assumption. Since there were no large deviations
from the normal line, the assumption was met (See Figure 4). To assess the assumption of
homoscedasticity, or equal variance of error terms, I created a scatterplot of the
standardized residuals as a function of the standardized predicted values. Since the points
are in a rectangular, regular distribution, the assumption was met (See Figure 5). Absence
of multicollinearity assumes that no two predictors are highly correlated. I checked this
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assumption with VIFs such that a value of 10 indicates that there is multicollinearity in
the predictors (Stevens, 2009). As the greatest value is 2.14, the assumption was met.

Figure 4. Normal P-P plot to check whether data used to assess the relationship between
the predictor variables and SC are normally distributed.
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Figure 5. Scatterplot of standardized residuals as a function of standardized predicted
values for SC.
As the assumptions were met, I ran the first multiple linear regression analysis for
Research Question 2. The results of the regression indicated insignificance, F(4,93) =
1.18, p = .326, R2 = 0.05 (See Table 6). For this research question, the null hypothesis
that no relationship exists between the four predictor variables and support of change was
not rejected.
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Table 6
ANOVA Results for Regression Two
Source

SS

df

MS

F

p

Regression 61.991
4 15.498 1.178 .326
Residual
1223.464 93 13.156
Total
1285.455 97
Based on the t-statistics and p-values in Table 7, I cannot conclude that the four
predictors made a significant model to predict SC. The results of the regression are
presented in Table 7.
Table 7
Results for Multiple Linear Regression to predict SC
Source

B

SE

β

T(98) Critical t

Constant 68.55 1.2
57.34
ICR
0.25 0.33 0.10 0.76
CHC
-0.16 0.29 -0.08 -0.56
ICD
0.56 0.61 0.10 0.91
PCS
0.32 0.33 0.14 0.97
Note. F(4,93) = 1.18, p = .326, R2 = 0.05

1.98
1.98
1.98
1.98
1.98

P
.001
.449
.579
.366
.333

Next, I conducted a third regression analysis to determine the collective
relationship between the four independent variables (ICR, CHC, ICD, and PCS) and CM.
I checked assumptions of normality, homoscedasticity, and absence of multicollinearity
before conducting the analysis. Normality assumes that the data follows a normal, bellshaped distribution. I used a normal P-P plot to check the assumption. Since there were
no large deviations from the normal line, the assumption was met (See Figure 6). To
assess the assumption of homoscedasticity, or equal variance of error terms, I created a
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scatterplot of the standardized residuals as a function of the standardized predicted
values. Since the points are in a rectangular, regular distribution, the assumption was met
(See Figure 7). Absence of multicollinearity assumes that no two predictors are highly
correlated. I checked this assumption with VIFs such that a value of 10 indicates that
there is multicollinearity in the predictors (Stevens, 2009). As the greatest value is 2.14,
the assumption was met.

Figure 6. Normal P-P plot to check whether data used to assess the relationship between
the predictor variables and CM are normally distributed.
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Figure 7. Scatterplot of standardized residuals as a function of standardized predicted
values for CM.
As the assumptions were met, I ran the multiple linear regression analysis. The
results of the regression indicated insignificance, F(4,93) = 1.44, p = .227, R2 = 0.06 (see
Table 8). For this research question, the null hypothesis that no relationship exists
between the four predictor variables and CM was not rejected.
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Table 8
ANOVA Results for Regression Three
Source

SS

df

MS

F

P

Regression 194.97
4 48.743 1.44 .227
Residual
3146.871 93 33.837
Total
3341.841 97
Based on the t-statistics and p-values in Table 9, I cannot conclude that the four
predictors made a significant model to predict CM. The results of the regression are
presented in Table 9.
Table 9
Results for Multiple Linear Regression to Predict CM
Source

B

SE

β

t(98)

Constant 49.36 1.92
25.75
ICR
0.83 0.53 0.20 1.55
CHC
-0.74 0.47 -0.23 -1.60
ICD
-0.68 0.98 -0.08 -0.69
PCS
-0.13 0.52 -0.04 -0.25
Note. F(4,93) = 1.44, p = .227, R2 = 0.06

Critical t

P

1.98
1.98
1.98
1.98
1.98

.001
.124
.114
.490
.803

Next, I conducted a fourth regression analysis to determine the collective
relationship between the four independent variables (ICR, CHC, ICD, and PCS) and CP.
I checked assumptions of normality, homoscedasticity, and absence of multicollinearity
before conducting the analysis. Normality assumes that the data follows a normal, bellshaped distribution. I used a normal P-P plot to check the assumption. Since there were
no large deviations from the normal line, the assumption was met (See Figure 8). To
assess the assumption of homoscedasticity, or equal variance of error terms, I created a
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scatterplot of the standardized residuals as a function of the standardized predicted
values. Since the points are in a rectangular, regular distribution, the assumption was met
(See Figure 9). Absence of multicollinearity assumes that no two predictors are highly
correlated. I checked this assumption with VIFs such that a value of 10 indicates that
there is multicollinearity in the predictors (Stevens, 2009). As the greatest value is 2.14,
the assumption was met.

Figure 8. Normal P-P plot to check whether data used to assess the relationship between
the predictor variables and CP are normally distributed.
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Figure 9. Scatterplot of standardized residuals as a function of standardized predicted
values for CP.
As the assumptions were met, I ran the multiple linear regression analysis. The
results of the regression indicated insignificance, F(4,93) = 1.25, p = .296, R2 = 0.05 (see
Table 10). For this research question, the null hypothesis that no relationship exists
between the four predictor variables and CP was not rejected
Table 10
ANOVA Results for Regression Four
Source

SS

df

MS

F

P

Regression 92.572
4 23.143 1.247 .296
Residual
1725.633 93 18.555
Total
1818.205 97
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Based on the t-statistics and p-values in Table 11, I cannot conclude that the four
predictors made a significant model to predict CP. The results of the regression are
presented in Table 11.
Table 11
Results for Multiple Linear Regression to Predict CP
Source

B

SE

β

t(98)

Constant 69.76 1.42
49.14
ICR
-0.22 0.40 -0.07 -0.56
CHC
-0.11 0.34 -0.05 -0.31
ICD
1.34 0.73 0.20 1.84
PCS
0.38 0.39 0.15 0.99
Note. F(4,93) = 1.25, p = .296, R2 = 0.05

Critical t

P

1.98
1.98
1.98
1.98
1.98

.001
.575
.754
.069
.325

I conducted the final regression analysis to determine the collective relationship
between the four independent variables (ICR, CHC, ICD, and PCS) and CH. I checked
assumptions of normality, homoscedasticity, and absence of multicollinearity before
conducting the analysis. Normality assumes that the data follows a normal, bell-shaped
distribution. I used a normal P-P plot to check the assumption. Since there were no large
deviations from the normal line, the assumption was met (See Figure 10). To assess the
assumption of homoscedasticity, or equal variance of error terms, I created a scatterplot
of the standardized residuals as a function of the standardized predicted values. Since the
points are in a rectangular, regular distribution, the assumption was met (See Figure 11).
Absence of multicollinearity assumes that no two predictors are highly correlated. I
checked this assumption with VIFs such that a value of 10 indicates that there is
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multicollinearity in the predictors (Stevens, 2009). As the greatest value is 2.14, the
assumption was met.

Figure 10. Normal P-P plot to check whether data used to assess the relationship between
the predictor variables and CH are normally distributed.
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Figure 11. Scatterplot of standardized residuals as a function of standardized predicted
values for CH.
As the assumptions were met, I proceeded with the regression analysis to
determine whether ICR, CHC, ICD, and PCS significantly predict CH. The results of the
analysis indicated that the model is statistically significant, F(4,93) = 5.24, p = .001, R2 =
0.18 (see Table 12). The results of the multiple linear regression indicated that the null
hypothesis was rejected in favor of the alternative, which states that a significant
relationship exists between the four predictor variables and CH.
Table 12
ANOVA Results for Regression Five
Source

SS

df

MS

F

P

Regression 429.176 4 107.294 5.236 .001
Residual
1905.832 93 20.493
Total
2335.008 97
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The R2 indicates that the model predicts 18% of the variability in the dependent
variable. Although the model is significant, there were no significant individual
predictors, as depicted by the t-statistics and p-values in Table 13. This is potentially due
to issues of multicollinearity, or shared significance among predictors, where the model
would be unable to determine specifically where significance lies (Stevens, 2009).
Perceived change success was the closest to being significantly predictive of CH, but
ultimately was found to be insignificant at an alpha of .05 (B = 0.70, t = 1.72, p = .089).
Because the regression equation was significant, the following equation may be used to
predict CH:
𝐶𝐻 = 0.15(𝐼𝐶𝑅) + 0.37(𝐶𝐻𝐶) + 1.01(𝐼𝐶𝐷) + 0.70(𝑃𝐶𝑆) + 86.52
The results are presented in Table 13.
Table 13
Results for Multiple Linear Regression to Predict CH
Source

B

SE

β

t(98)

Critical t

Constant 86.52 1.49
57.99
ICR
0.15 0.42 0.04 0.37
CHC
0.37 0.36 0.14 1.01
ICD
1.01 0.77 0.14 1.32
PCS
0.70 0.41 0.24 1.72
Note. F(4,93) = 5.24, p = .001, R2 = 0.18

1.98
1.98
1.98
1.98
1.98

P
.001
.716
.313
.189
.089

Summary of Results
For Research Question 1, the results suggest that an aggregate model of ICR,
CHC, ICD, and PCS predicts RC (F(4,93) = 5.50, p = .001, R2 = 0.19). However, the
multiple linear regression did not find a significant individual predictor.
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For Research Question 2, the results suggest that there is insufficient evidence to
conclude that ICR, CHC, ICD, and PCS predict SC (F(4,93) = 1.18, p = .326, R2 = 0.05).
However, ICR, CHC, ICD, and PCS, in the aggregate, were found to predict the CH
subscale of SC (F(4,93) = 5.24, p = .001, R2 = 0.18). As in the regression used to predict
RC, the model could not identify an individual independent variable with significant
predictive ability.
Summary of Chapter
Chapter Four presented a brief summary of the purpose and problem statement to
contextualize the results prior to discussing the field test and initial data-screening that
occurred before presenting the analyses. I presented sample characteristics and
descriptive statistics. I then described and presented detailed analyses in order of the
relevant research questions and hypotheses. Finally, I examined the hypotheses so that
they could be either accepted or rejected and concluded with a summary of the results. I
will discuss the implications of these results in the next chapter in the context of the
existing literature and practice.
In summary, the four independent variables (ICR, CHC, ICD, and PCS) in the
aggregate significantly predicted RC, and though they did not significantly predict SC
overall, they did predict the CH subscale of SC. None of the independent variables
individually predicted RC or SC. Of the four independent variables, ICR was the only one
that trended towards predicting RC, but the association was not significant. Likewise,
PCS was the closest variable to being a significant predictor of CH, though this
association was also not significant.
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
The purpose of this quantitative, correlational study was to narrow the knowledge
gap on large-scale organizational change in the pharmaceutical industry. I did so by
measuring whether any of several factors predict employee response to large-scale
change initiatives, such as M&As, in the pharmaceutical industry. The independent or
predictor variables were the four factors I hypothesized affect the change’s
implementation: participants’ initial reactions, participants’ involvement in the change
design, participants’ perceptions regarding the successfulness of the change, and the
frequency and quality of communication about the change. The two dependent variables
were reaction to change and operationalized measures of support of change. Reaction to
change includes the full spectrum of reactions ranging from a negative reaction of active
resistance to a positive reaction of championing change; operationalized measures of
support of change is an index computed by combining the subscales of compliance,
cooperation, and championing.
The problem addressed in this study was a limited understanding of the factors
that predict employee response to large-scale change in the pharmaceutical industry.
Researchers have studied employee response to change in many industries, including law
enforcement (Ford et al., 2003), the hospitality industry (Hartline & Ferrell, 1996), and
the electronics industry (Goksoy et al., 2012). However, there was no information in the
literature on the study of employee response to large-scale organizational change in the
pharmaceutical industry. This was the case despite the fact that the industry frequently
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engages in M&As, a common type of large-scale organizational change, 50-80% of
which usually fails, according to Budhwar et al. (2009), for reasons related to
communication and employee engagement. Additionally, risk of failure is high in the
pharmaceutical industry, as only 1 in 10,000 discovered compounds make it from the
laboratory to market, according to Cook et al. (2009) and costs $1.8 billion in doing so,
based on Golec et al.’s 2009 estimate. Failed mergers have immediate negative effects in
the communities in which these pharmaceutical companies operate, as the failed entities
may go out of business, resulting in major job losses. In addition to the financial and
business challenges, a failed merger in the pharmaceutical industry has a significant
potential to negatively affect the participating companies’ development of medicines and
other medical innovations to fulfill global health needs.
This chapter begins with a summary of the results of the study. I then interpret the
results and discuss how they extend knowledge in the area of change management within
the pharmaceutical industry. After reviewing key limitations, such as those related to the
quantitative methodology and generalizability outside the pharmaceutical industry, I
present recommendations for future research, review implications for organizational
change and positive social impact, and conclude after discussing recommendations for
professional practice.
Summary of Key Results
This study was designed to answer two research questions:
1. What is the relationship between RC and the predictor variables ICR, ICD, PCS,
and CHC?
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2. What is the relationship between SC and the predictor variables ICR, ICD, PCS,
and CHC?
For Research Question 1, the results suggest that in the aggregate, the four
independent variables predict reaction to change. However, none of the predictors
individually predicted reaction to change.
For Research Question 2, the research failed to find sufficient evidence to
conclude that the factors, in the aggregate, predict support of change. However, the
factors in the aggregate, were found to predict the championing sub-scale. As in the
regression used to predict reaction to change, the model could not identify an individual
independent variable with significant predictive ability.
Interpretation of Results
How Results Confirm and Disconfirm Knowledge in the Discipline
Reaction to change. I selected the factors evaluated in my study because
previous researchers found that one or more of these factors predicted employee response
to change and lead to change success in other industries. These industries included law
enforcement (Ford et al., 2003), the hospitality industry (Hartline & Ferrell, 1996), the
electronics industry (Goksoy et al., 2012), and the publishing industry Franckeiss (2012).
In a 2012 study of a global print-based publishing company that was transitioning to
digital formats, Franckeiss found that various hands-on change inclusion techniques and
frequent change communication through webinars before, during, and after change
implementation increased change success. Goksoy et al. (2012) found that
communication with employees during and after the change are a crucial success factor in
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organizational change. My results, however, did not align with the findings of previous
studies, as none of the factors (participants’ initial reactions, involvement in the change
design, perceptions regarding the successfulness of the change, or communication about
the change) individually predicted employees’ reaction to change.
However, my results did support previous research that showed change is
multidimensional and best examined through multidimensional approaches (Herscovitch
& Meyer, 2002). It is likely that there are different factors related to employee reactions
to change in the pharmaceutical industry than those of other industries. Additional factors
related to employee reactions to change from recent research have included behavioral
and attitudinal components (Jaros, 2012), emotional factors (Mishra & Bhatnagar, 2010),
and factors related to employees’ ambivalence toward change (Oreg & Sverdlik, 2011).
In addition, recent research in other industries found that change leadership
(Charbonnier-Voirin, El Akremi, & Vandenberghe, 2010; Ricke-Kiely & RobeyWilliams, 2011; Wang & Rode, 2010) and employees’ prior change experiences (Bordia
et al., 2011) both predict employees’ reactions to change. These prior findings all suggest
that a combination of factors influence employee reaction to change.
These two factors (change leadership and employees’ prior change experiences)
might be related to employees’ reaction to change in the pharmaceutical industry as well
and could be the subject of future research. In addition, Oreg and Sverdlik (2011) found
that employees’ reactions to change could be ambivalent, suggesting the necessity of
more nuanced approaches to employees’ reactions to change that can account for how
employees can both resist (the actual change) and support (through positive feelings
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about the change agent) aspects of the same change. Although change may be best
approached as a multidimensional construct, as it is in other industries, it may be
necessary for researchers to discover what specific individual factors relate to employee
reaction to change in the pharmaceutical industry.
Support of change. Based on a review of the literature, I hypothesized that the
opinions employees form or behaviors they exhibit upon first learning about a change
predict or influence how much they support the change. I also hypothesized that the
quality and frequency of the initial and subsequent change communication, the level of
employee involvement in the change development, and perceptions of the change’s
success influence the degree to which employees support change in the pharmaceutical
industry. However, my results in the pharmaceutical industry did not confirm previous
findings from other industries that employee involvement in change or communication
regarding change, taken individually or in the aggregate, predict their support of change.
Jaros (2010) and Whelan-Berry and Somerville (2010) found that employee involvement
in change predicted employee support of change. Jaros (2010) found that getting
employees to commit to new procedures, policies, and goals involving change increased
the likelihood of change success. This means that other factors specific to the
pharmaceutical industry could influence employee support of change and are worth
evaluating in a future study.
The commitment to the new operating norm Jaros (2010) described may be hard
to achieve without a comprehensive, multidimensional approach to change management.
Whelan-Berry and Sommerville (2010) mentioned resource requirements as one key
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component of large-scale change that change leaders and human resource personnel are
responsible for, which is often overlooked during change implementation. In the same
study, Whelan-Berry and Sommerville mentioned communication and employee
participation among the contributors to successful change. In addition, Goksoy et al.
(2012) and Whelan-Berry and Somerville found that clear communication regarding
organizational change was important for employee adoption and support of change.
Much of the relevant literature appears to support my results related to reaction to
change, that a number of factors in the aggregate foster a positive reaction to change.
However, when comparing existing literature to my results related to support of change,
the result is different, as the four independent variables in the aggregate did not predict
support of change. When the subscales of support of change were isolated and considered
separately, however, the independent variables in the aggregate predicted the
championing subscale. Individually, none of the independent variables predicted support
of change or any of its subscales.
Reflecting on the responses on the change continuum ranging from active
resistance to championing change, only 5.1% of the 98 participants fell in the
championing change category (See figure 12). This 5.1% is an interesting result because
the four independent variables predicted championing, indicating that when employees
display the most enthusiastic, supportive change behaviors, the change is likely to be
successful, provided other aspects of the change are proceeding well. My results on
employees’ championing change suggest connections between employees’ support of
change and stakeholder theory, one of the three theoretical frameworks I will cover in the
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next section. Employees are supportive and enthusiastic when they feel they are
important to an organization’s overall success and when leaders treat them as
stakeholders (Duckworth, 2014). Viewing employees as stakeholders with an interest in
an organization’s overall success may help change leaders and managers establish
bottoms-up approaches to include employees in change processes and to facilitate
employees’ championing of change (Duckworth, 2014) to ensure change success.

5.1%

3.1%
11.2%
Active Resistance

28.6%

Passive Resistance
Compliance
Cooperation
Championing
52.0%

Figure 12. The distribution of responses to reaction to change.
Interpretation of Results in Relation to Theoretical Framework
I framed this study with a synthesis of transformational leadership theory,
stakeholder theory, and change management theory. I selected these theories because
they all relate to employee engagement during organizational change. Burns’s (1978)
transformational leadership theory involves the use of motivation and inspiration to
obtain desired actions and outcomes from employees. It is also considered a reciprocal
relationship in which both manager and employee elevate each other to higher levels of
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success, according to Burns. Freeman’s (1984) stakeholder theory is about justice,
acknowledgment, and fair treatment of those with a vested interest or stake in an
organization. Finally, and since change usually involves some disruption, Lewin’s (1947)
3-stage change management model, which is to unfreeze the current situation, make the
change, and then stabilize or refreeze the situation, seemed an appropriate theoretical
framework to understand change processes in relation to the pharmaceutical industry.
Lewin’s 3-stage change management model offered a theoretical lens through which to
examine initial change reaction, involvement in change design, perceived change success,
and change communication in relation to large-scale change of established practices in
the pharmaceutical industry.
Based on the results of my study, it may be possible to construct a more effective
change management process with an optimum mix of leadership and employee
engagement. Charbonnier-Voirin et al. (2010) noted that transformational leadership is
the type required for effective change management because transformational leaders use
motivation and inspiration to help employees adapt to organizational change.
Charbonnier-Voirin et al. contended that creating a work environment conducive to
innovation fosters better change adoption at individual and team levels. Actual
characteristics or predispositions that would create that environment and signal how
employees respond to change, however, were not addressed. Similarly, Wang and Rode
(2010) discussed a comprehensive approach to change that emphasized the value of
context in facilitating change. According to Wang and Rode, employee engagement
during change is important. The effects of employee engagement during change,
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however, can be optimized in an innovative, transformational leadership environment,
where employees identify with leaders. In my study, I isolated a combination of four
factors (initial change reaction, involvement in change design, perceived change success,
and change communication) that can assist, in the aggregate, in creating such an
environment. In addition, transformational leadership techniques, such as motivation,
inspiration, and recognizing that employees are important stakeholders, may help change
leaders engage better with employees during organizational change to help ensure change
success.
Successful organizational change requires a balanced approach that acknowledges
various stakeholder needs. According to Duckworth (2014) and Parmar et al. (2010),
decisions and actions regarding change intimately and directly affect employees. For this
reason, employees are important stakeholders to engage in organizational change.
Applying stakeholder theory, employees may be considered crucial stakeholders in an
organization, and research (Jaros, 2010; Whelan-Berry & Somerville, 2010) shows that
employees’ participation in change endeavors is a key factor to successful organizational
change implementation. A balanced, stakeholder-oriented approach to organizational
change should address the views, concerns, needs, and efforts of various stakeholders,
especially those of employees, when considering and managing change. An integrated
approach that considers employees as important stakeholders to engage in organizational
change necessary for change success, may also include a balanced approach that
considers all of the variables of initial change reaction, involvement in change design,
perceived change success, and change communication, individually and in the aggregate.
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In addition, my results related to the championship subscale suggest a connection
between seeing employees as stakeholders and employees championing change.
Employees are supportive and enthusiastic when they are involved, feel instrumental to
an organization’s overall success, and when leaders treat them as stakeholders
(Duckworth, 2014). My results on the championing change sub-scale suggests that
transformational leadership during change might include ensuring that employees are
made to feel like stakeholders with an interest in the organization. In addition,
stakeholder theory may offer a way to better understand that successful change should
include a balanced approach that considers a variety of strategies when it comes to
employee concerns, and may have a specific connection to employees championing
change by involving them and making them feel crucial to an organization’s success.
Although Lewin’s (1947) 3-stage change management model has become
foundational to the study of organizational change, Marks and Mirvis (2011) cautioned
that there is no one-size-fits-all approach to organizational change. The results of my
study suggest that factors connected to the unfreezing of established approaches (i.e.,
reaction to change and support of change; Whelan-Berry & Sommerville, 2010) could not
be predicted by initial change reaction, involvement in change design, perceived change
success, and change communication, individually. Consequently, the results do not
support targeting any of these components individually to help successfully unfreeze
established practices in facilitating successful change. However, initial change reaction,
involvement in change design, perceived change success, and change communication
may be used in the aggregate to generate information that could be used to help unfreeze
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established practices in relation to reaction to change and the championing subscale of
support of change.
The findings from this study partially support the use of Lewin’s change
management model in relation to information regarding reaction to change and the
championing subscale of support of change. The findings of this study do not support the
use of the unfreezing stage of Lewin’s change management model to inform support of
change. This is the case because the four independent variables (initial change reaction,
involvement in change design, perceived change success, and change communication)
did not predict support of change individually or in the aggregate, but it could be used for
the championing subscale of support of change.
How Findings Extend Knowledge in the Discipline
Major change initiatives are usually initiated in response to internal and external
pressures. Organizations merge and remove management layers in response to a
challenging economic climate. Fletcher (2009) likened this need for change or adaptation
to that of a burning platform. In discussing this burning platform metaphor, Fletcher
noted that organizations make bold, radical moves to stay competitive. Other researchers
have taken a different perspective. According to Judge, Bowler, and Douglas (2006),
organizations do not need to wait until they are essentially forced to change, and should
always be prepared for change. According to Judge et al., organizations should have a
change strategy that includes a contingent of change agents who are ready to facilitate
change initiatives. Lucey (2008) concurred with this perspective and suggested that
change provisions include both a communication plan and change agents. A key role for
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these change agents is to ensure that employees at all levels of the organization are
involved in the change. Change agents can do so through soliciting feedback in informal
settings and delivering the feedback to management for action and communication back
to employees.
Change initiatives have not traditionally focused on people as the primary target.
According to Pellissier (2011), regardless of the change rationale, change model,
philosophy, and selected change management tools, the emphasis of change initiatives is
usually directed at specific processes or products. When employee response to change
has been studied, it has been in other industries. Researchers have not paid enough
attention to how engaged employees are during the change process in the pharmaceutical
industry.
My study, however, adds important, empirical data to the change management
literature on employee response to change in the pharmaceutical industry. We now know
that a combination of actions representing the four independent variables (initial change
reaction, involvement in change design, perceived change success, and change
communication) influences reaction to change. We also know that in the pharmaceutical
industry, these variables independently do not influence reaction to change. When
focused on the supportive side of employee response to change, ranging from mere
compliance to championing, the four independent variables (in the aggregate or
individually) did not influence support of change. However, the four independent
variables significantly predicted the championing subscale of support of change. In
addition, the findings of this study support the use of transformational leadership and
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stakeholder theory, but to a lesser extent the use of Lewin’s change management model
to inform and frame organizational change. This is useful information for pharmaceutical
organizations contemplating large-scale change such as M&As.
Limitations of the Study
Limitations to Generalizability
The focus of this study was on the pharmaceutical industry, specifically on how
pharmaceutical industry employees perceived large-scale organizational change. The
sample included a diverse set of pharmaceutical industry job roles, including research
scientists; support roles, such as IT and project management; executives; middle
management; and one change management expert. This mix of job roles approximately
reflects the typical distribution of job roles at a pharmaceutical company. Consequently,
the results may be generalizable within the pharmaceutical industry. Beyond the
pharmaceutical industry, however, the results may not be applicable and need to be
interpreted with caution.
Limitations to Validity and Reliability
One key assumption in the proposal was that participants would respond honestly
to the survey questions. There is no evidence to believe that participants were dishonest
or thoughtless in responding to the survey. The Cronbach’s alpha reliability analysis for
the support of change variable had excellent reliability (α = .93). This degree of reliability
is indicative of thoughtful and consistent responses to the scale (George & Mallery,
2010).
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Another potential area of concern was ensuring that each participant completed
only one survey. The Survey tool tracked the IP address of the participants’ devices and
assigned a unique participant code. There was also no evidence that any participant
completed more than one survey. The above concern represented potential limitations
that did not affect the validity and reliability of this study.
Potential limitations to internal validity arise when assumption tests indicate a
violation to a statistical assumption (Stevens, 2009). In my study, each of the assumptions
of the analyses (i.e., normality, homoscedasticity, and absence of multicollinearity) was
met, and the analyses may be assumed to be accurate and empirically valid. In addition,
the final sample used in the analysis was found to be sufficiently large to carry out the
regression analyses based on an a-priori sample size calculation, which contribute to
trustworthy results.
Recommendations for Future Research
The sample contained a diverse mix of pharmaceutical industry employees,
including scientific research roles, various project management and supportive roles, as
well as management and executive roles. There was also one change management expert
and a large category of other roles. One suggestion for future research is to segment and
categorize pharmaceutical industry employees and study whether different groups, based
on position, level, or role, respond to change differently. For example, a pharmacist,
treating physician or nurse interacting directly with patients may not respond to change
the same way a pharmaceutical company employee would. This difference could be
because pharmaceutical company employees do not routinely interact with patients
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directly and are more focused on discovery, development, and commercialization of
pharmaceutical products, giving them a different perspective. Although both categories of
employees share the same goal of improving lives through their work, their contribution
and vantage points are quite different. In addition, employees may have differing roles in
organizational change based on their positions and levels that would affect how they
respond to change. It would therefore be interesting to see if these differences could be
examined in a scholarly study.
My selection of a quantitative method to study employee response to change in
the pharmaceutical industry means that I traded rich details, typically associated with
qualitative research, for statistical certainty that associations did not occur by chance. The
four independent variables, together, significantly predicted reaction to change as well as
the championing subscale of support of change. Although there was no individual
predictor, initial change reaction came close to predicting reaction to change and
perceived change success came close to predicting the championing subscale of support
of change. Both of these variables could influence change communication and are worth
further study using either a qualitative or mixed method approach to get a deeper
understanding of the potential role initial change reaction and perceived change success
play in facilitating successful organizational change.
Avenues for future research might also include study of the format or type of
communication used to inform employees initially of change in relation to ICR. The form
of communication used to convey the information might influence employees’ initial
experience with organizational change. For example, initial change communication could
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take the form of a live, in-person meeting, a web-based meeting with video, a
teleconference, a memo sent through the mail or email. Since the type of the initial
change communication can vary, the type of format used to convey organizational change
might influence employees’ initial reaction to change.
The results also suggest that more research is needed to identify other predictive
factors in relation to employees and change that are specific to the pharmaceutical
industry. These might include employees’ ambivalence toward change (Oreg & Sverdlik,
2011) and prior change experiences (Bordia et al., 2011). Additionally, researchers might
also test how stakeholder theory is related to employees championing change and their
support and enthusiasm for change when they are involved and feel they are important to
an organization’s overall success as stakeholders.
Implications
Organizational Change Implications
Of the 98 participants in my study, only 3.1% described themselves as having
actively resisted change, and only another 11.2% passively resisted change. Although it is
possible that respondents to this type of survey were those more likely to support change,
organizations should be encouraged by the low percentage of employees who resist
change. This finding creates an opportunity for organizations to leverage the fact that the
vast majority of employees support organizational change. What is interesting, however,
is that of those who supported change, a majority (60.7%) simply comply, providing
minimal support. Organizations can create a more targeted approach to change
management that incorporates the findings from my study. Such approach could identify
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and help convert some employees passively resisting change and move the compliant
employees up the reaction to change continuum, making them more supportive of
change.
The results imply that a combination of factors, such as initial change reaction,
involvement in change design, perceived change success, and change communication,
can facilitate a better reaction to change. Large-scale changes, such as M&As, are
strategic events with several proprietary and confidential elements. This poses a
communication challenge to senior management, who may not be authorized to share
many aspects of the change freely. This reality makes it difficult to incorporate the
findings of this study in the design and implementation of organizational change, as
communication and employee involvement are vital to the way employees react to
organizational change. Therefore, managers contemplating change need to consider and
decide from the outset what information to share with employees, communication
frequency, and how much to engage employees in the process. This practice may be
different from the traditional approach of focusing on the financial and regulatory aspects
of the deal first, then worrying about change implementation and employee reaction later.
Positive Social Change Implications
Pharmaceutical industry employees are very much interested in creating social
change. The intent of their research and development efforts is frequently to discover and
develop medicines that fulfill unmet medical needs and improve the quality of life of
individuals in societies around the world. In many cases, the medicines and other
scientific innovations are life-saving, which is the ultimate testament of the potential
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positive impact of their work on social change. Given the magnitude of the opportunity
for social change in this profession, it is important for socially responsible organizations
to create an environment in which such employees can have their greatest impact. Such
environment can lead to better performance and focus during organizational change,
effectively enabling employees to fulfill their mission of improving lives through their
work developing medical innovations.
With this new knowledge of the key factors that predict employee reaction to
change, the industry is positioned to implement sound change management practices
during organizational change. To improve the probability of a more positive change
reaction, all four independent variables must be considered before, during and after
implementing large-scale change, as individually they do not influence reaction to
change. Although the association was only directional and not significant, based on the
multiple regression analysis, change leaders should pay particular attention to the mode
and content of the initial change communication, as it could influence whether employees
support or resist organizational change.
Recommendations for Practice
In announcing organizational change initiatives, especially those as large as an
M&A, organizations must be careful in communicating the right type and amount of
information. Although all affected parties can benefit from a general overview of the
change, each stakeholder or category of stakeholders will need more information on
specific aspects of the change they deem more relevant to them. As such, the organization

116
should create a change communication plan that addresses this need. Table 14 is an
example of the diversity in information needs related to a contemplated change.
Table 14
Stakeholder Information Needs
Stakeholder

Type

Information Need

Managers

Primary

Employees who execute
the process
Process management head
or change management
professional
Other functional areas
External clients

Primary

Intended business benefits and resources
needed
Reason for change in process and detailed
procedures
Realization metrics and scope of change

Primary

Secondary
Secondary

Awareness of process change
Awareness of process change components
that affect interactions with them

A well-coordinated process that considers a variety of change dimensions is
needed for successful change implementation. Such a process might consist of an
approach that does not single out any one factor, but employs a combination of four
factors (initial change reaction, involvement in change design, perceived change success,
and change communication) that can assist in creating an environment of successful
organizational change in pharmaceutical organizations. A well-coordinated process might
also ensure that key players are aware of the decisions and the role they need to play to
support it. Watson (2005) described this process as policy deployment, the second of a
four-step approach to organizational strategy. The other steps are policy setting,
implementation, and review. Watson's description is similar to sigma methodology,
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except that Watson begins with an identified solution and focuses on achieving the
intended goals of that solution.
In addition to communication and employee involvement, good process
management is essential to successful change implementation. In a large-scale
organizational change situation, such as an M&A, the organizations should consider
using various process management tools to foster communication up, down, and across
the organization. First, the organizations should establish a process realization office.
This office would be responsible for coordinating all formal integration-related
communication, including town hall meetings to present high-level integration strategies.
This central office could serve as a trusted source of merger- or integration-related
information, create consistency in messaging, and represent a communication brand for
the change initiative. With such an organized process, employees would know where to
go for reliable organizational change information.
Second, it is useful to establish a network of change agents to solicit feedback
from peers in informal settings. According to Barratt-Pugh et al. (2013), in a study of the
merger of two state government departments in Western Australia, employees had a
positive experience with change when change agents used informal, relational techniques.
With the feedback from the informal interactions, change leaders can adjust aspects of the
implementation plan to meet stakeholder needs more effectively. This network of change
agents will address a critical need to acknowledge and respond to stakeholder concerns
during change implementation. Incorporating feedback through this communication
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vehicle even after the major change decisions have been made can be a useful way to
gain additional support for the change.
As noted in the sample characteristics, one participant was a change management
expert with six sigma expertise. A close examination of the responses from this
participant revealed that the participant responded very positively to the questions related
to the championing subscale of support of change. The participant was actively involved
in the change process, perceived the quality and frequency of change-related
communication highly favorably, and scored perceived change success very highly. The
responses also indicate that the participant maintained an optimistic perspective of the
change and influenced others to support the change. This participant essentially modeled
the behaviors implied in my recommended actions to improve the probability of
successful organizational change in the pharmaceutical industry.
These recommendations, if executed well, may foster a positive or supportive
reaction to change. They address aspects of the four independent variables, which my
study demonstrated influences reaction to change and the championing subscale of
support of change when considered in the aggregate. The communication plan ensures
the frequency and quality of communication, which can in turn elicit a positive initial
reaction if handled well. Leveraging a network of change agents to interact with
employees at all levels of the organization is a good way to keep employees involved.
Doing so gives employees a voice and a feeling that their opinions and concerns matter,
which could give them an overall feeling that the change may be successful.
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Conclusion
The purpose of this quantitative, correlational study was to narrow the knowledge
gap on large-scale organizational change in the pharmaceutical industry. This was an
important study because the pharmaceutical industry frequently engages in M&As, a type
of large-scale organizational change, 50-80% of which fail because of poor
communication, lack of employee involvement, and clashing corporate cultures,
according Budhwar et al. (2009). Researchers have studied employee response to
organizational change in many industries, including law enforcement (Ford et al., 2003)
the hospitality industry (Hartline & Ferrell, 1996), and the electronics industry (Goksoy
et al., 2012). However, they have not focused on employee response to change in the
pharmaceutical industry, even though Cook et al. (2009) and Golec et al., (2009)
indicated that it is one of the most expensive and high-risk industries. It is also an
industry with strong potential for positive social change impact due to the nature of the
work discovering and developing medical innovations to save and improve lives, while
fulfilling global health needs.
The results indicate that deploying a change management strategy that considers a
combination of four factors, which were the independent variables in my study, can foster
a positive, supportive employee reaction to change in the pharmaceutical industry. These
four factors were initial change reaction, involvement in change design, perceived change
success, and change communication. These individual factors on their own may not result
in a positive response to change, as individually, they were not significant in any of the
regression analyses. To maximize the value of this key finding when contemplating
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organizational change, managers should create a targeted change management strategy
that, at a minimum, includes a contingent of change agents to facilitate informal
employee engagement, a stakeholder information needs analysis for timely and relevant
dissemination of information, and a process realization office responsible for
communication quality, frequency, and consistency.
Although the results of my study confirm that change is best examined as a
multidimensional construct, the factors of the construct might be particular to the
organizational needs and change dynamics of the pharmaceutical industry. As such, the
study offers researchers encouragement and direction to identify additional factors,
specific to the pharmaceutical industry, which may predict employee response to change.
It also creates an opportunity to develop a better understanding of the connection between
employee support of change and the enthusiasm employees feel for change as
stakeholders. Finally, the findings that only a small percent of employees resist change
and majority of those who support change merely comply, is an opportunity for managers
to create enthusiasm and build support for change, starting with the initial change
communication. Doing so might convert some of the few that may otherwise resist
change and move up the change reaction spectrum those who only comply or cooperate.
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I have attached the behavioral support measures you requested along with some more
resent articles and measures you might find of interest. I hope all goes well with the
research.

Best regards,
John Meyer

----- Original Message ----From: Otis Johnson
To: meyer@uwo.ca
Cc: james.stewart@waldenu.edu
Sent: Tuesday, March 06, 2012 10:10 PM
Subject: Request for Instrument and Usage Permission

Dear Dr. Meyer,
My name is Otis Johnson, a Ph.D. student at Walden University School of Management. I
am currently conducting research on the factors that predict employee response to
change. I would appreciate very much if you would kindly grant me permission to use the
Behavioral Support for Change Scale from your 2002 publication with Dr. Herscovitch
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(titled: Commitment to organization change: Extension of a three component model). I
would also appreciate a copy of the actual scale.
Thanks,
Otis Johnson
PhD Candidate: Management
Specialization: Leadership and Organizational Change
Student ID: A00136499
Phone: 908-487-1624

Otis Johnson <otis.johnson@waldenu.edu>

12/29/14 (6
days ago)

to John

Dear Dr. Meyer,

Thank you for sharing these instruments and papers with me. I took some time off from
school to take a new job, but now I am working towards finishing my dissertation in
2015.

I will use your behavioral support for change scale (BSCS), but need to add a few
questions upfront to learn about the study population and to ask questions that would help
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announcement, change communication quality and frequency, involvement in change
implementation, and perceived change success) and compliance, cooperation and
championing (dependent variables).

Would you kindly allow me to modify the BSCS instrument by adding these questions? I
would appreciate your reply with approved.

Thanks,
Otis Johnson
PhD Candidate: Management
Specialization: Leadership and Organizational Change
Student ID: A00136499
Phone: 908-487-1624
Email: otis.johnson@waldenu.edu

John Meyer

12/30/14 (5
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Dear Otis,
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Yes, you can add any questions you would like – our BSCS assesses only one set of
variables that might be of interest in studying organizational change. I hope all goes well
with your research.

Best regards,
John Meyer

Dr. John Meyer
Department of Psychology
Rm 8411, Social Science Centre
Western University
London, Ontario, Canada
N6A 5C2

Phone: (519) 661-3679
Fax: (519) 661-3961
Email: meyer@uwo.ca
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Appendix B: IRB Approval Letter
Dear Mr. Johnson,
This email is to notify you that the Institutional Review Board (IRB) has approved your
application for the study entitled, "Evaluating Key Predictors of Employee Response to
Change in the Pharmaceutical Industry."

Your approval # is 07-02-15-0136499. You will need to reference this number in your
dissertation and in any future funding or publication submissions. Also attached to this email is the IRB approved consent form. Please note, if this is already in an on-line format,
you will need to update that consent document to include the IRB approval number and
expiration date.

Your IRB approval expires on July 1, 2016. One month before this expiration date, you
will be sent a Continuing Review Form, which must be submitted if you wish to collect
data beyond the approval expiration date.

Your IRB approval is contingent upon your adherence to the exact procedures described
in the final version of the IRB application document that has been submitted as of this
date. This includes maintaining your current status with the university. Your IRB
approval is only valid while you are an actively enrolled student at Walden University. If
you need to take a leave of absence or are otherwise unable to remain actively enrolled,
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may occur while a student is not actively enrolled.

If you need to make any changes to your research staff or procedures, you must obtain
IRB approval by submitting the IRB Request for Change in Procedures Form. You will
receive confirmation with a status update of the request within 1 week of submitting the
change request form and are not permitted to implement changes prior to receiving
approval. Please note that Walden University does not accept responsibility or liability
for research activities conducted without the IRB's approval, and the University will not
accept or grant credit for student work that fails to comply with the policies and
procedures related to ethical standards in research.

When you submitted your IRB application, you made a commitment to communicate
both discrete adverse events and general problems to the IRB within 1 week of their
occurrence/realization. Failure to do so may result in invalidation of data, loss of
academic credit, and/or loss of legal protections otherwise available to the researcher.

Both the Adverse Event Reporting form and Request for Change in Procedures form can
be obtained at the IRB section of the Walden website:
http://academicguides.waldenu.edu/researchcenter/orec
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participant log sheets, completed consent forms, etc.) for the same period of time they
retain the original data. If, in the future, you require copies of the originally submitted
IRB materials, you may request them from Institutional Review Board.

Both students and faculty are invited to provide feedback on this IRB experience at the
link below:
http://www.surveymonkey.com/s.aspx?sm=qHBJzkJMUx43pZegKlmdiQ_3d_3d

Sincerely,
Libby Munson
Research Ethics Support Specialist
Office of Research Ethics and Compliance
Email: irb@waldenu.edu
Fax: 626-605-0472
Phone: 612-312-1283
Office address for Walden University:
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139
Information about the Walden University Institutional Review Board, including
instructions for application, may be found at this link:
http://academicguides.waldenu.edu/researchcenter/orec
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Appendix C: IRB-Approved Informed Consent Form
INFORMED CONSENT
Pharmaceutical company employees who have experienced a large-scale organizational
change in their company are invited to take part in a research study. This is a study of
opinions about organizational change and how employees perceive it. Because these
issues are only relevant to those who have experienced such a change, and who have
opinions on this matter, you must have recent memory of such an event. This form is part
of a process called “Informed Consent”, to allow you to understand this study before
deciding whether to take part. Do not indicate your name or any other identifying
information on the materials. This study is being conducted by a researcher named Otis
Johnson, Walden University.
Procedures:
Participation in this research study is completely voluntary. There is no penalty if you
decide not to participate. If you agree to participate in this study, you will be asked to
complete a questionnaire. The process will take approximately 30 minutes or less to
complete. Questions on these assessments will ask you about your initial reaction to the
change, perceptions of its success, and support of the change. Samples of some of the
questions and prompts include the following:
a) Rank your initial reaction when you first learned about the change (1 = I
am going to lose job; 7 = I am going to get promoted).
b) How involved were you in the development of the change initiative?
Response options are not involved, consulted, actively involved.
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c) Rank the following item on a 7-point Likert scale (1 = strongly agree; 7 =
strongly disagree): I remain optimistic about the change even in the face of
diversity.
Risks and Benefits of Being in the Study:
Risks to participation are minimal, and include only slight discomfort in responding to
the questions should you recall unpleasant memories from your organization’s change.
Though you may not directly benefit from this study, the benefits to the population
include a better understanding of factors that contribute to successful change in large
organizations.

The contact information for individuals regarding this study is: (a) the researcher, Otis
Johnson (otis.johnson@waldenu.edu) (b) the researcher’s committee chairperson, Dr.
Branford McAllister (branford.mcallister@waldenu.edu), and (c) the Walden
representative who can be contacted if you have questions about your rights as a
participant, irb@waldenu.edu.
Compensation:
There is no monetary compensation for participation in this study.
Confidentiality:
Any information you provide will be kept anonymous. The researcher will not use your
information for any purposes outside of this research project. Also, the researcher will not
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include anything that could identify you in any reports of the study. This study will not
ask for your name or any identifying information. It is completely anonymous and you
are requested not to provide your name on any of the materials.
Contacts and questions:
If you have any questions, you may contact the researcher via telephone at 908-487-1624.
If you would like to talk privately about your rights as a participant, you can contact the
Walden IRB representative. This representative can discuss this with you and may be
contacted through irb@waldenu.edu. Walden University’s approval number for this study
is 07-02-15- 0136499 and it expires on July 1, 2016.
Statement of Consent:
To protect your privacy, no consent signature is required. By pressing accept below and
submitting your completed survey via SurveyMonkey, you have given your consent for
your information to be used in this study. Please print a copy of this form for your
records. Thank you for your participation in this study.

